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Abstract 
Abstract 
The endoplasmic reticulum (ER) is the site of oxidative folding for proteins entering the 
secretory pathway. Here, nascent polypeptides acquire disulfide bonds, which confer both 
stability and functionality on secretory and ER-resident proteins. In eukaryotes, this 
process is catalysed by the disulfide oxidoreductase protein disulfide isomerase (PDI). 
Many mammalian homologs of PDI have been described including the pancreas-specific 
homolog PDIp. PDI is 'recharged' by the disulfide oxidoreductase Ero. Accepted 
electrons are then passed to molecular oxygen via an Ero-bound flavin adenine 
dinucleotide (FAD) molecule. 
We provide data showing that human Erol-L(3 protein is able to form disulfide-dependent 
homodimers //; vivo. We also provide evidence that the yeast G252S and H254Y FAD-
binding mutants exhibit reduced affinity for PDI. Since the Ero 1-La C391A mutant can 
rescue the ero 1-1 temperature-sensitive mutant, Ero-PDI association and Ero-Ero 
dimerisation may be significant in maintaining the oxidative protein folding pathway in 
the ER. Homodimerisation was not affected by FAD-binding mutants, suggesting that the 
erol-1 and erol-2 phenotypes cannot be accredited to the failure of Erolp to 
homodimerise. We also make the first steps towards characterising the interactions of 
PDIp with the human Ero I - L a and Erol-Lp proteins. In order to observe protein-protein 
interactions, we characterise a polyclonal anti-Erol-Lp antibody for intended use in 
immunoprecipitations and immunoblotting. 
I V 
Abstract 
Quality control measures are in place to ensure that only natively folded proteins are 
permitted to exit the secretory pathway. Chaperone molecules such as immunoglobulin-
binding protein (BiP) retain unfolded or misfolded proteins in the ER, which are 
eventually retrotransiocated out of the ER and degraded. When misfolded proteins 
accumulate in the ER, however, the folding capacity of the ER may be exceeded. This 
triggers a cellular response pathway called the unfolded protein response, aimed at 
restoring homeostasis in the ER via transcription regulation and translational attenuation. 
We provide evidence that misfolding/misoxidation of the major histocompatability 
complex (MHC) class I heavy chain HLA-B27 in HeLa cells causes the UPR to be 
triggered. Possession of the HLA-B27 allele in lymphoblastoid cell lines results in some 
UPR signalling. Interestingly, analysis of IREl-medialed X B P l splicing shows a distinct 
difference in sensitivity of the UPR to induction by the pharmacological agents 
dithiothreitol (DTT) and tunicamycin. Since possession of HLA-B27 is highly associated 
with development of the chronic inflammatory disease ankylosing spondylids, induction 
of the UPR as a consequence of HLA-B27 misfolding may have implications in disease 
pathogenesis. 
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1. Introduction 
1.1 General Introduction 
In order for proteins to can y out their specific biological function they must assume their 
correct conformation, folding into the precise three-dimensional structure required for 
functional activity. This correct conformation is based upon the primary amino acid 
structure. Establishment of the secondary structure of proteins is characterised by the 
spontaneous formation of alpha-helices and beta-sheets. 
For proteins entering the eukaryotic secretory pathway, formation of a tertiary or 
quaternary protein structure takes place in the endoplasmic reticulum (ER) (Gething and 
Sambrook, 1990; Jessop et oL, 2004; Kemmink et a/., 1996). The secretory pathway 
describes the route taken by proteins destined for the extra-cellular environment, be it 
cell-surface expression or secretion. ER resident proteins are also folded in the ER. 
Progression through the secretory pathway involves entry of nascent poly-peptides into 
the ER, post-translational modifications, the adoption of their secondary, tertiary and 
possibly quaternary structures and their trafficking to the cell surface in secretory vesicles 
via translocation to the Golgi (Jessop et ah, 2004)(Fig. 1). 
Oxidative folding and the addition of disulfide bonds characterises the tertiary structure 
of secretory proteins. Disulfide bonds are formed in the ER via adjacent free cysteine 
residues, forming an S-S bridge upon oxidation of two thiol groups (Anfinsen et al, 
1961) (Fig. 2). Disulfide bonds are slow to form spontaneously and it was discovered by 
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Cytosol 
Lumen 
Cytosol 
Extracellular 
Ribosome 
Nascent 
Polypeptide 
Transport 
Vesicle 
Golgi 
Apparatus 
Secretory 
Vesicles 
Figure 1. A model of the secretory pathway. Nascent polypeptides are co-translated into the ER 
where they undergo folding events, eventually adopting their native conformation. Fully folded proteins are 
then transported to the Golgi where they are packaged into secretory vesicles and fuse with the plasma 
membrane and are released into the extracellular space. 
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Goldberger and colleagues in 1963 that this reaction is in fact catalysed in vivo 
(Goldbergere?«/ . . 1963). 
H 3 N — c — c ; H,N C C 
3 1 
H,N-
S!! 
C H , 
Disulfide Bond 
H,N C C ' 
Figure 2. Disulfide bond formation. Disulfide bonds form between two cysteine residues. The thiol 
group (-SH) on the side chain of the amino acid takes part in a thiol-disulfide exchange with a 
oxidoreductase catalyst resulting in a covalent S-S disulfide bond between two cysteine side chains. 
The formation of inter-chain disulfide bonds plays a vital role. As well as increasing 
protein stability in the extra-cellular environment, disulfide bridges confer functionality 
on secretory proteins (Shiroishi et a/., 1984). Establishment of disulfide bonds is regarded 
as one of the final steps in the maturation of secretory proteins. 
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Being the site of oxidative folding, the protein composition (Benhani and Braakman. 
2000; Trombetta and Parodi, 2003; Tu and Weissman, 2004) and redox environment 
(Hwang et ciL, 1992) within the ER is distinct from that of the cytosol. The method by 
which the cell controls the ER redox environment is partially understood. It is believed, 
however, that glutathione is the major redox buffer in eukaryotic cells (Hwang et al, 
1992). The ratio of reduced glutathione (GSH) to oxidised glutathione (GSSG) is -100:1 
in the cytosol compared with -3:1 in the ER. Thus, the oxidising environment in the ER 
favours disulfide bond formation. 
1.2 Protein folding in the pwkaryotes 
1.2.1 The Bacterial Dsb family 
It was studies with the bacterium Escherichia coli that lead to the identification and 
characterisation of the first bacterial redox protein, DsbA (Bardwell et al, 1991; 
Kamitani et al, 1992; Raina and Missiakas, 1997). Bardwell and colleagues studied the 
DsbA null mutant dsbA which exhibited compromised disulfide bond formation. This 
initiated an effort to identify other redox proteins using genetic screens based on the 
ability or inability of E. coli cells to cope with changes in the redox environment 
(Missiakas et al, 1993; Missiakas et al., 1994; Missiakas et al, 1995; Shevchik et al., 
1994). The result of this effort was the identification of other E. coli Dsb proteins and 
their relationship with the cytoplasmic redox protein thioredoxin and the glutaredoxins 
(See Table 1). 
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Table 1 - The various redox proteins of E. coli 
Gene name Protein name Mw of 
monomer 
(kDa) 
Cellular location Funct ion 
(pH7, 30°C) 
dsbA DsbA 21 Periplasm Oxidant 
dsbB DsbB 20 inner membrane Oxidant 
dsbC DsbC 2 x 2 3 Periplasm Disulfide isomerase 
dsbD DsbD 50 inner membrane Reductant 
dsbE DsbE 20 Periplasm Reductant 
trxA Thioredoxin 12 Cytoplasm Reductant 
trxB Thioredoxin reductase 2 X 70 Cytoplasm Reductant 
grxA Glutaredoxin 1 10 Cytoplasm Reductant 
grx B Glutaredoxin 2 27 Cytoplasm Reductant 
grx C Glutaredoxin 3 10 Cytoplasm Reductant 
gor Glutaredoxin reductase 48 Cytoplasm Reductant 
gshA Glutathione synthetase - Cytoplasm synthesises the 
tripeptide glutathione 
Reproduced from (Raina and Missiakas, 1997) 
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The structure, biochemistry and function of thioredoxin. the four Dsb proteins and the 
three glutaredoxins (Table I) have since been extensively studied (Akiyama et ah, 1992; 
Andersen et «Z., 1997; Chen et <://., 1999; Holmgren, 1985; Holmgren, 1988; Holmgren 
and Aslund, 1995; Kamitani et al., 1992; Xiao et al, 2005; Zapun et «/., 1995). These 
proteins are not identical, however they all exhibit redox activity. Both thioredoxin and 
the glutaredoxins act as reductants, as do DsbD and DsbE. DsbA and DsbB function as 
oxidants while DsbC acts as a disulfide isomerase (Table 1). Al l these proteins carry an 
active-site containing two cysteine residues in a C-X-X-C formation which is typically 
refen-ed to as a thioredoxin domain. Consequently, these proteins are collectively refeired 
to as the thioredoxin super-family. The actives site cysteines may exist as two species; in 
their reduced fonn, Dsb-(SH)2, or in their oxidised form, Dsb-S? with an intramolecular 
disulfide bond between the two cysteines. In the C-X-X-C motif of the Dsb proteins the 
A^-terminal cysteine is solvent exposed and has a very low pK;, value - around 3.5 in 
DsbA (Nelson and Creighton, 1994). Thus, the terminal cysteine of the Dsb proteins is 
fully deprotonated and found as a thiolate ion with a negative charge. The difference in 
stability of the reduced and oxidised forms of Dsb is a consequence of the stabilisation of 
this negative charge (Nelson and Creighton, 1994). This stabilisation effect drives the 
reaction between oxidised DsbA and reduced substrate proteins, since the reduction of 
DsbA is more favourable. Residues in the vicinity of the active site cysteines play an 
important role. Histidine 32, which lies within the C-X-X-C motif is significant in 
determining the redox properties of DsbA (Grauschopf et al, 1995). Point mutation of 
this residue leads to a dramatic decrease in redox potential, diminishing the ability of 
DsbA to donate disulfide bonds. It has been proposed that electrostatic interactions, 
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absent in the histidine mutant, are responsible for stabilising the thiolate anion of the N-
terminal cysteine (Guddat et al., 1997). 
1.2.2 Thioredoxin and Glutaredoxin 
Thioredoxin is one of the best characterised redox enzymes. It is a small ubiquitous 
protein that is evolutionarily conserved across both prokaryotes and eukaryotes and, as a 
consequence of its redox active cysteine residues, serves as a model for our 
understanding of E. coli Dsb proteins and the eukaryotic equivalents; the protein disulfide 
isomerase-like subfamily. The crystal structure of E. coli thioredoxin was solved by Katti 
and colleagues in 1990 at a high resolution of 1.68 A (Katti et al., 1990) (Fig. 4). The 
highly conserved, characteristic thioredoxin fo ld comprises a P-a-p-a-(3-a-(3-P-a 
structure encompassing the reactive C-X-X-C motif (Katti et al., 1990). 
1.2.3 Tinoredoxin super-family properties 
Members of the thioredoxin super-family have been shown to directly pass 
intramolecular disulfide bonds to protein substrates by cycling between dithiol and 
disulfide forms during catalysis (Darby and Creighton, 1995a; Darby and Creighton, 
1995c; Holmgren, 1995). Cycling between redox states mediates the transfer of redox 
equivalents between enzyme and substrate. When the active site of the thioredoxin super-
family exists in its reduced form (TSF-S2), the N-terminal cysteine in the C-X-X-C motif 
becomes deprotonated at physiological pH. and is essentially exposed (Kemmink et al., 
1996). This nucleophillic cysteine is consequently able to react with the sulfhydryl (-SH) 
groups of protein substrates thus forming what is termed a 'mixed disulfide' (Walker et 
Introduction 
al., 1996). The C-terminal cysteine, however, is buried within the ihioredoxin fold and 
characteristically reacts with the A^-terminal cysteine alone (Kemmink et ciL, 1996). Of 
course, if the enzyme is a reductant, or isomerase, the thiolate attacks a disulfide bond of 
the substrate, again forming a mixed disulfide (Holmgren, 1995; Jeng et ciL, 1998). The 
mixed disulfide is resolved by attack from the other active site cysteine. 
Although members of the super-family share a degree of structural similarity, each 
member can exhibit different activities. The common thioredoxin motif which they share 
permits a degree of functional flexibility, allowing isomerisation, reducing and oxidising 
activities. The specificity of the family members is to a certain extent determined by 
their environment. DsbA is localised in the oxidising environment of the bacterial 
periplasm thus acts as an oxidase whilst Glutaredoxin I is a good reductant as a 
consequence of its localisation in the reducing cytoplasm of E. coli. Different members 
also exhibit unique chemistry, each mixed disulfide occurring with a distinct stability and 
reactivity (Wundeiiich et al, 1993; Zapun et al, 1993; Zapun et ai, 1995). This is 
mainly due to differences in the pK^ values of the nucleophillic cysteine and their redox 
potential (Carvalho et ciL, 2006) (Table 2). This difference is due, in part, to the identity 
of the two X-X residues that are flanked by the active cysteines (Chivers et al., 1996; 
Huber-Wunderlich and Glockshuber, 1998; Krause et al., 1991) (Fig. 3). 
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Thioredoxin Cys-Gly-Pro-Cys 
DsbA Cys-Pro-His-Cys 
DsbB Cys-Val-Leu-Cys 
DsbC Cys-Gly-Tyr-Cys 
DsbD Cys-Val-Ala-Cys 
DsbE Cys-Pro-Thr-Cys 
PDI Cys-Gly-His-Cys 
Reproduced from Raina & Missiakas, 1997 
Figure 3.Thiol/disulfide active site motifs from various members of the thioredoxin super-
family. 
Reproduced from SOling el al, 1999 
Figure 4. Ribbon model of the crystal structure of E. coli thioredoxin. As determined by Katti 
and colleagues (KattI etal., 1990). The cysteine residues of the active site (green), Asp26 are shown as 
ball and stick representations. a-Helical elements are shown in red and p-elements in yellow. 
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The functional roles of the much-studied thioredoxin super-family are wide and varied. 
DsbA is a potent catalyst of peptide oxidation (Wunderlich et al., 1993; Zapun and 
Creighton. 1994). however, because of its rapid activity, errors often occur in processing, 
resulting in inconect, non-native disulfides forming. The isomerisation of these disulfides 
is carried out by dimeric DsbC (Rybin et al.. 1996; Sone et al., 1997; Zapun et al., 1993). 
As a consequence of this, the effect of the d.sbC null mutation on the growth of E. coli is 
not as strong as either the dsbA or dsbB null mutations (Rietsch et al., 1996). DsbC 
exerts isomerase activity on incon-ectly formed disulfide bonds. Evidence of this comes 
from studying proteins targeted to the periplasm. Urokinase, a protein that contains 12 
disulfide bonds is undetectable in the DsbC null mutant. However, the yield of alkaline 
phosphatase, which only contains two disulfide bonds, is only lowered by 15% (Rietsch 
et al., 1996). DsbA is recycled by DsbB located in the inner membrane of E. coli, 
delivering electrons to the electron transport chain (Kobayashi et al., 1997). DsbD 
maintains DsbC and DsbG in their reduced forms by receiving electrons from 
cytoplasmic thioredoxin (Chung et al., 2000; Joly and Swartz, 1997). The role of the 
glutaredoxins is as reductants, however the mechanisms are slightly more complex 
involving the participation of glutathione and glutathione reductase which together 
regenerate the reduced enzyme (Fernandes and Holmgien, 2004; Yang and Wells, 1991). 
Thioredoxin reduction is achieved by thioredoxin reductase by a similar mechanism 
(Holmgren, 1988; Holmgren, 1989). 
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Table 2 - Redox potential and pK^ values of members of the thioredoxin super-family 
Member name Function Redox 
potential 
(mV) 
Reference 
value 
Reference 
Thioredoxin Reductant -270 (Miranda-Vizuete et 
al., 1997) 
6.3-10 (Aslund et al.. 1994; Chivers ef a/., 
1997; Dillet ef a/., 1998; Dyson et al., 
1991; Forman-Kay et al., 1992; 
Klappa etal., 1998a; Langsetmo et 
al., 1991; Puig etal., 1994; Tagaya et 
al., 1989; Wetterau etal., 1990) 
DsbA Oxidant From -90 
to-125 
(Hoog et al., 1983; 
Huber-Wunderlich 
and Glockshuber, 
1998; Wilson etal., 
1995; Wunderlich 
and Glockshuber, 
1993) 
3.5 (Grauschopf ef al., 1995; Jeng ef al., 
1995; Mossner etal., 1998; Vlamis-
Gardikas and Holmgren, 2002) 
<4 (Darby and Creighton, 1995a) 
Glutaredoxini Reductant -233 (Aslund ef a/., 1994) 3.8 (Gan and Wells, 1988; Yang and 
Wells, 1991) 
Glutaredoxin2 Reductant -198 (Aslund ef a/., 1994) 
PDI Oxidant, -180 (Lundstrom ef a/., 
Isomerase 1992) 
4.5 (Kortemme and Creighton, 1995) 
6.7 (Freedman etal., 1988) 
<5 (Darby and Creighton, 1995b) 
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1.3 Protein folding in the eitkaryotes 
1.3.1 PDl structure and function 
Long before the characterisation of DsbA however, a protein able to rearrange incorrect 
disulfide bonds and catalyse the oxidation and reduction of disulfide bonds in eukaryotes 
was identified (Goldberger et al., 1963). By studying the reactivation of ribonuclease as a 
model for the formation of natively folded secretory proteins, Goldberger and colleagues 
were able to isolate a key redox enzyme which was subsequently named protein disulfide 
isomerase or PDI. Since its initial discovery, PDl has been the subject of intense 
examination and has become the archetypal eukaryotic disulfide oxidoreductase. PDl is 
thought to be the primary catalyst of protein folding involving disulfide bond formation 
in the eukaryotic endoplasmic reticulum. Interestingly, it has been shown to complement 
DsbA deficient E. coli, increasing the yield of heterologous!y expressed disuifide-
containing proteins in both E. coli and cultured insect cells (Hsu et al., 1996; Ostermeier 
etai, 1996). 
In 1985, over 20 years after the initial discovery of PDI, Edman and colleagues managed 
to sequence PDl and publish data on the domain architecture of the oxidoreductase 
(Edman et f//., 1985). They provided structural evidence showing that mammalian PDl is 
composed of four thioredoxin-like domains tenned a, b, b' and a' and an anionic tail 
named c. PDl also contains an /V-terminal signal sequence and a - K D E L ER retrieval 
sequence at the C-terminus (Edman et al., 1985). The catalytic domains a and a' possess 
the characteristic thioredoxin fold and are located towards the two ends of the molecule 
(Fig. 5). These domains not only possess the thioredoxin fold but in fact show high 
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sequence homology to thioredoxin (Ferrari et al., 1998). Each active site possesses the 
two catalytic cysteines, between which lie a glycine and histidine residue (Fig. 3). Thus, 
it is the a and a' domains that contribute to the thiol disulfide exchange activity o f PDI. 
Flanked by the two active domains are the non-catalytic b and b' domains. Despite not 
participating directly in oxidoreductase fiinction, these domains are thought to be 
important for the disulfide rearrangement activities o f PDI (Kemmink et al., 1997) and 
possibly substrate binding activity (Klappa et al., 1998a). This muUi domain structure 
differs from the single thioredoxin fold o f DsbA and thioredoxin itself 
115 120 217 219 350 352 462 463 491 
a' 
Figure 5. PDI domain structure. PDI consists of 2 active site thioredoxin-like domains a and a 'and 
two non-reactive thioredoxin-lil<e domains b and b'. The boundaries for the domains a and b are those 
defined by NMR (Kemminl< etal., 1999). Reproduced from (Kemmink etal., 1997) 
PDI is a highly abundant ER resident protein, making up approximately 0.8% of total 
cellular protein (Freedman et al., 1994). Much like thioredoxin, PDI is highly conserved 
between species. PDI is essential for eukaryotic oxidative protein folding; as illustrated 
by its requirement for S. cerevisiae viability (Farquhar et al., 1991). 
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1.3.2 Catalytic activity ofPDI 
The redox activity of PDI is due to the reactivity of the N-terminal cysteine residue in the 
two thioredoxin-hke C-X-X-C motifs. Like other members of the super-family, the 
function of PDI is defined by the biochemistry of the sequence both immediately 
sunounding and within the active site, as well as the residues and features of the three-
dimensional environment suiTOunding the reactive cysteines. It has been shown that the 
p^a value of the N-terminal cysteine of the active site is 4.5 (Table 2) and that this 
reactive cysteine is stabilised by the histidine residue within the thioredoxin fold (Fig. 3) 
and by the partial positive charges at the N-terminus of an a-helix occurring soon after 
the catalytic cysteine (Kortemme and Creighton, 1995). Together, these features generate 
a less stable disulfide bonded protein which is responsible for the oxidative function of 
PDI. This has been contrasted with the relatively more stable oxidised version of 
thioredoxin, which permits its reductant capabilities (Freedman et ah, 1995). 
As previously discussed, the redox function of an oxidoreductase is in part determined by 
its immediate redox environment. The redox environment of the ER favours the oxidation 
of disulfide bonds reflected by the relatively high lumenal concentration of GSSG. The 
redox activity of PDI is accounted for by the presence of the two-thioredoxin-like motifs 
CGHC. Oxidation of the substrate requires conversion of an active site disulfide to a 
dithiol, while reduction requires the conversion of a dithiol active site to a disulfide. 
There is, however, plenty of evidence showing that the major function of PDI is not as an 
oxidase or reductase but as an isomerase (Gilbert, 1998; Schwaller et r//., 2003; Walker 
and Gilbert, 1997). Isomerisation results in no net redox state change but requires the 
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breaking of a substrate disulfide for rearrangement. Isomerisation therefore requires the 
active site cysteines of PDI in their reduced form so they may attack non-natively formed 
substrate disulfides, catalysing their rearrangement. Both the active sites have been 
shown to contribute to PDI activity. In 1994, however, a study suggested that the two 
domains are not equivalent in their catalytic properties, with the amino-terminal domain 
providing the majority of catalytic activity and the carboxyl-terminal domain being 
involved in steady-state binding of the substrate (Lyles and Gilbert, 1994). However, a 
more recent study shows that it is the b ' domain that provides the principle peptide-
binding site of PDI (Klappa et al, 1998a). Recent work by Kulp and colleagues also 
endeavoured to study the domain architecture of PDI and also reported an asymmetry in 
function, albeit dissimilar f rom Lyles & Gilbert's report (Kulp et ai, 2006). They 
provided evidence showing an asymmetry of rate of oxidation of PDI by its natural 
oxidant endoplasmic oxidoreductase 1 protein (Erolp), which wil l be discussed later. 
This has a dual effect; allowing an enhanced rate of oxidation of the second catalytic 
domain (a') and the substrate-mediated inhibition of oxidation of the first catalytic 
domain (a). This asymmetry permits the two active thioredoxin-like folds to exhibit two 
distinct functional roles. The C-terminal active site (a') is efficient at oxidising RNase A 
but defective at catalysing the formation of native disulfides. Conversely, the N-terminal 
active site (a) is a poor oxidase but conects non-native disulfide bonds, reairanging them 
to produce a functional RNase A protein. 
Using the substrate bovine pancreatic ribonuclease A (RNase A) , Walker and colleagues 
aimed to study PDI active site mutants in order to gain an insight into the oxidase and 
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isomerase activity iit vivo. Four mutants were produced, each one possessing a single 
active site cysteine. Kinetic analysis of these mutants showed that the N-terminal 
cysteines of each active site are essential for oxidation and reairangement during the 
refolding of reduced RNase A (Walker et al., 1996). The C-tenninal active site cysteines 
were not essential for isomerisation activity but were essential for RNase A oxidation. It 
was suggested therefore that the C-terminal cysteines provide PDI with an escape from 
covalent disulfide bond intemiediates of RNase A during isomerisation. A more recent 
study using shuffled domain mutants in the Apdi l null strain of yeast, suggests that most 
of PDPs multidomain structure is dispensable for its essential function in yeast and that 
only low level (<5%) isomerase activity is required for yeast viability (Xiao et cil., 2001). 
Contrastingly, it has been shown that high redox and isomerase activity of PDI on bovine 
pancreatic trypsin inhibitor (BPTI) requires both the redox-inactive (b and b') and redox 
active (a and a') domains (Darby et al., 1998). However, the only shuffled domain 
mutant used by Xiao and colleagues that exhibited levels of isomerase activity 
comparable to wild-type possessed the b' a' c domains, suggesting that one or more of 
the b domains may be important in isomerase activity. Since the b' domain has been 
implicated in substrate-binding (Klappa et al., 1998a), it may be feasible that this domain 
could potentially recognise misfolded proteins, an essential part of the isomerase 
pathway. 
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1.3.3 Other functions of PDI 
1.3.3.1 Chaperone activity 
PDI exhibits chaperone activity, a non-redox related function of PDI. The responsibility 
of ER-resident molecular chaperones (Ellis and Hemmingsen. 1989) is to bind to 
misfolded proteins in order to a) inhibit aggregation and to b) prevent misfolded proteins 
from exiting the ER and traversing through the secretory pathway. Molecular chaperones 
do not directly accelerate folding itself but seek to increase the quality of proteins exiting 
the ER, ensuring proteins that do so are natively folded and thus functional. ER-resident 
chaperones wi l l therefore bind with nascent polypeptides entering the ER. 
Disulfide oxidoreductases should only require catalytic concentrations in order to 
facilitate disulfide bond formation or rearrangement. It is interesting that PDI exists at 
millimolar concentrations in the ER. With studies showing PDI being essential for cell 
viability and Apf//7 null mutations of yeast being rescued by mammalian PDI with little 
foldase capability, it seems that some other function of PDI is essential for yeast viability. 
In order for PDI to exhibit its isomerase activity, direct recognition of misfolded proteins 
would allow the oxidoreductase to perform rearrangement of non-native disulfide-bonded 
substrates. LaMantia & Lennarz were able to demonstrate the binding of unfolded 
proteins by PDI, suggesting that the oxidoreductase may demonstrate chaperone activity 
(LaMantia and Lennarz, 1993). This was investigated by Puig & Gilbert in 1994 by 
studying the folding of the enzyme lysozyme (Puig and Gilbert, 1994). They were able to 
demonstrate chaperone-like activity of PDI increasing the recovery of lysozyme by 
preventing aggi-egation. Interestingly they discovered a novel anti-chaperone activity, 
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where the yield of native lysozyme is substantially lower in the presence of PDI than in 
its absence. This facilitated the formation of inactive disulfide cross-linked aggregates 
and retained misfolded proteins in the ER when the level of unfolded protein exceeded 
the chaperone and foldase capacity of the ER (Puig and Gilbert, 1994; Puig eJ al., 1994). 
Whether this proposed activity is functionally significant in vivo is unknown. However, it 
has been suggested that anti-chaperone activity is a consequence of multivalent binding 
of partially aggregated substrates to PDl (Primm et al., 1996). Considering PDI exists at 
millimolar concentrations in the ER, folding substrates in vivo are unlikely to be subject 
to conditions in which PDI has significant anti-chaperone activity. 
1.3.3.2 The P subunit of collagen prolyl 4-liyclroxylase 
Collagen prolyl 4-hydroxylase (CP4H) is an enzyme which catalyses the formation of 4-
hydroxylprolines in the collagens. The formation of 4-hydroxylproIines is essential for 
the formation of the collagen triple helix at body temperature (Myllyharju, 2003). The 
enzyme exists as an aj^i tetramer in vertebrates with a molecular weight of 240 kD with 
the individual subunits being 63 kD and 55 kD respectively (Berg and Prockop, 1973; 
Pankalainen et ah, 1970; Tuderman et al., 1975). The p subunit of CP4H was cloned in 
1987 and was found to be identical to PDI (Koivu et al., 1987; Pihlajaniemi et al., 1987). 
When (3 subunits were removed from CP4H, they had no prolyl 4-hydroxylase activity 
but did have approximately 50% of the wild-type PDI activity in rean-anging the disulfide 
bonds of scrambled RNase A and even when present as an a 2 P 2 tetramer. PDI redox 
activity is not required for tetramer assembly or for prolyl 4-hydroxylase activity. No 
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high resolution structure exists for CP4H. therefore the position of PDI in the tetramer 
and the orientation of the subunits within the enzyme are unknown. 
Various studies have shown that the absence of the p subunit causes the a subunit to 
aggregate resulting in a loss of activity (Helaakoski et al., 1995; Kivirikko and Myllyla, 
1982; Veijola et al., 1994; Vuori et al., 1992). The primary function of PDI in CP4H 
appears to be to keep the a subunit in a soluble state. Since the a subunit does not 
possess an ER retention signal, PDI may also be responsible for retaining the enzyme in 
the lumen of the ER (Vuori et al., 1992). 
1.3.3.3 ne P siibunit of microsomal triglyceride-transfer protein 
The microsomal triglyceride-transfer protein (MTP) is a 155 kD protein which catalyses 
the transport of triglyceride, cholesteryl ester and phosphatadylcholine through 
membranes. In addition, MTP is required for the assembly of apoB-containing 
lipoproteins in the liver and intestinal cells. MTP exists as an a(3 heterodimer with 
subunits weighing 97 kD and 55 kD respectively. The smaller 55 kD subunit has been 
identified as PDI (Wetterau et al., 1990). The larger a subunit is active only in the 
complex; however, the isolated PDI subunit has no lipid-transfer activity. As with 
collagen prolyl 4-hydroxylase, PDI may serve to retain MTP in the lumen of the ER, 
since the a subunit lacks an ER retrieval signal. In the absence of PDI, the a subunit 
aggregates, as in CP4H. The role of PDI might also be to maintain the a subunit in its 
soluble form (Wetterau et al., 1991). The redox activity of PDI is not required for MTP 
activity or formation of the heterodimer (Lamberg et al.. 1996). 
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1.3.3.4 Retiotraii.slocatioii 
Recent studies have highlighted a role for PDI in retrotranslocation and subsequent 
degradation of protein substrates (Forster et «/., 2006; Tsai and Rapoport, 2002; Tsai et 
rt/., 2001). PDI is able to bind polypeptides in the reduced state and unfolded these 
substrates for retrotranslocation. Heterodimeric cholera toxin from Vibrio cholerae was 
used to study this. After secretion, the A subunit is cleaved into the A l toxic domain and 
the A2 domain which are connected by a disulfide bond. In the ER, the A subunit hijacks 
the retrotranslocation machinery so that the A l domain reaches the cytosol where it is 
resistant to proteasomal degradation (Rodighiero et al., 2002). In vitro studies revealed 
that, acting as a redox-driven chaperone, PDI is responsible for unfolding the A and A l 
domain preparing the toxin for retrotranslocation (Tsai et al., 2001). PDI may change its 
affinity for substrates during cycles of oxidation and reduction of disulfide bonds, binding 
maturing unfolded proteins when oxidised and unfolding proteins for retrotranslocation 
when in a reduced state. Thus, PDI may function as a novel chaperone. 
1.3.4 The PDI family 
As in prokaryotes, there are numerous oxidoreductase homologous to PDI in both yeast 
and mammalian cells. The group of mammalian PDI homologs includes ERp57, ERp72, 
P5, PDIR, PDIp. ERp44, ERp29, ERpI8, ERdj5, PDILT and EndoPDI. Like PDI, the 
majority of these are multidomain foldases that possess the characteristic thioredoxin 
fold. Many of these proteins also possess the C-X-X-C active site that provides 
thioredoxin with its redox activity. Few endogenous substrates have been identified for 
PDI homologs, hence it is not clear whether these PDI homologs serve a role in 
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reduction, oxidation or disulfide isomerisation in the ER. However, many homologs have 
been implicated in a wide range of processes including recruitment to large multi-protein 
complexes and recognition of misfolded proteins. The mammalian PDI homologs PDIp 
and ERp57 are especially interesting in that they share similar domain organisation to 
PDI as well as a strong overall sequence homology. They do however exhibit significant 
sequence variation in the b' domain, responsible for substrate binding, suggesting that 
these PDI isoforms may demonstrate specialised substrate binding properties (KJappa et 
al., 1998a). A summary of the function and features of some of these homologs is 
provided in Table 3. 
1.3.4.1 ERp57 
One of the best characterised PDI homologs is ERp57 (ER-60/ERp60/GRP38Q2/HIP-
70). Research on ERp57 has revealed that it has a similar domain organisation to that of 
PDI (Alanen et al., 2003; Ferrari and Soling, 1999) and possesses two thioredoxin-like 
domains, a and a ' , both containing C-H-G-C active sites in similar positions to those of 
PDI. ERp57 differs however in its ER retention sequence, possessing a QEDL variant. 
Overall sequence identity between PDI and ERp57 is 29% and similarity is 56% 
(Koivunen et al., 1996). ERp57 has been shown to exhibit thiol-dependent reductase 
activity similaj- to that of PDI (Bourdi et al, 1995; Hirano et al., 1995; Srivastava et al., 
1993). Despite such similarity in structure and function, ERp57 is unable to substitute 
PDI as the P subunit in collagen prolyl 4-hydroxylase (Koivunen et al., 1996). 
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Tab le 3 - Eukaryotic homologs of Protein Disulf ide Isomerase 
Protein name Size Number of Distinctive 
(kDa) ' Thioredoxin- features 
like domains 
(CXXC) 
Domain 
archi tecture 
References 
S . cerevisiae 
h o m o l o g s 
Pdi1p 58 Essential for 
viabil i ty 
a b b' a ' c (LaMant ia and 
Lennarz, 1993; 
Scherens et al., 
1991) 
M p d i p 36 a c (Tachikawa ei at, 
1995) 
Mpd2p 32 a c (Tachikawa et at, 
1997) 
Eug1p 58 CXXS active site a b b' a ' c (Tachibana and 
Stevens, 1992) 
E p s i p 
S e l e c t e d 
mammal ian 
homologs 
81 ER- membrane a c 
protein 
(Wang and Chang, 
1999) 
PDI 55 
ERp72 71 
General peptide-
binding site 
mapped to b' 
domain 
Calc ium binding 
a b b' a ' c 
a b b' a ' c 
(Edman et at, 
1985; Ferrari and 
Sol ing, 1999; 
Klappa et at, 
1998a) 
(Ferrari and 
Sol ing, 1999; 
Lundstrom-Ljung 
etat, 1995; 
Mazzarel la ef at, 
1990; Nigam et at, 
1994) 
ERp57 54 Interact ion with a b b' a ' c 
nascent 
monoglycosylated 
glycoproteins 
(Ferrari and 
Sol ing, 1999; 
Hirano et at, 1995; 
Molinari and 
Helenius, 1999; 
Ol iver et at, 1997; 
Zapun ef at, 1998) 
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P5 46 1 a c (Ferrari and 
Sol ing, 1999; 
Ful lekrug et at, 
1994; Lundstrom-
Ljung et at, 1995) 
PDIR 57 1 b a a a (Ferrari and 
Sol ing, 1999; 
Hayano and 
Kikuchi , 1995) 
PDIp 55 2 Pancreas-specif ic a b b ' a ' c (Desi lva ef a/., 
express ion 1997; Ferrari and 
Sol ing, 1999) 
' Size of yeast proteins are obtained by predicting the molecular weights based on full DNA sequence and do not reflect 
signal-sequence cleavage or glycosylation of the proteins in vivo. 
Reproduced from (Frand etal., 2000) supplemented with data from (Freedman etal., 2002) 
ERp57 is distinct in its function to bind glycoproteins. Evidence for this has coine from 
cross-linking experiinents revealing interactions between ERp57 and glycoproteins and 
either the lectin-like proteins calnexin and calreticulin (Oliver et a/., 1997). Calnexin and 
calreticulin are both ER-resident chaperones that interact specifically with glycoproteins, 
aiding folding and providing quality control. They are able to recognise 
monoglucosylated proteins via either the P-domain of calreticulin and the luininal domain 
of calnexin (Ellgaard et al., 2001; Schrag et al.. 2001). Both calreticulin and calnexin can 
bind processed N-glycans moieties of the form GlcNAc2Man9Glci (Rodan et al., 1996). 
One well characterised function of ERp57 is as an important component of the major 
histocompatability complex (MHC) class 1 peptide loading complex. ERp57 is found in 
association with the heavy chain-P2tTi dimers together with calreticulin (Dick et al., 2002; 
Hughes and Cresswell, 1998). Details of the modes of association of the peptide loading 
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complex have been extensively studied and have given rise to a proposed scheme in 
which class I heavy chains bind calnexin immediately upon translocation and 
glycosylation, and calreticulin replaces calnexin when p^m associates. ERp57 is believed 
to promote appropriate disulfide bond formation in the class I heavy chain. 
1.3.4 Protein misfolding and ER-associated degradation 
Since it is possible for any two cysteines, present in the primary structure of a 
polypeptide, to form a disulfide, it is of the utmost importance that proteins that are 
misfolded, be identified and folded into their native conformations. As discussed, PDI 
exhibits isomerase function to correct the formation of these non-native structures. Many 
chaperone molecules, including PDI, have been shown to be extremely important in 
retaining misfolded proteins in the ER (Ellgaard et al., 1999; Hurdey et al., 1989). 
Terminally misfolded proteins, that is, proteins that will never adopt their native 
formation cannot very well be bound to ER chaperones indefinitely. The fate of these 
aberrant proteins therefore is to be retro-translocated out of the ER via either the Sec61 
channel or p97/Derlin-l and degraded by the proteasome in a process known as ER-
associated degradation (ERAD) (Bonifacino and Weissman, 1998; Brodsky and 
McCracken, 1999; Carlson et al., 2006; Plemper and Wolf, 1999; Sun et al., 2006; Tsai et 
al., 2002). 
When protein misfolding exceeds the capacity of the ER to retrotran sloe ate and degrade 
proteins, cellular responses endeavour to restore homeostasis. The transmembrane ER 
sensors I R E l , ATF6 and PERK all associate with BiP in the ER lumen. When BiP is 
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sequestered away from these ER sensors to bind misfolded proteins, the cytosolic portion 
of these proteins is activated, triggering the unfolded protein response (UPR). IRE I , 
AFT6 and PERK work directly or indirectly to upregulate transcription of genes involved 
in ER regulation such as chaperones and ER-associated degradation (ERAD) machinery 
or to attenuate translation in order to increase the folding capacity of the ER. The UPR 
wil l be discussed further in Chapter 3.4. 
1.4 The ER-resident Ero protein 
1.4.1 Yeast EraIp 
The relative abundance of GSSG in the ER led to the theory, proposed in the key paper 
by Hwang and colleagues in 1992, that oxidised glutathione might serve as the source of 
oxidising equivalents utilised during disulfide bond formation in vivo (Hwang et al., 
1992). Papers by Fraud and Kaiser (1998), Cuozzo & Kaiser (1999) and Pollard and 
colleagues (1998), however, provided evidence to suggest that glutathione is in fact not 
essential for oxidative protein folding in the ER and disulfide bond formation relies upon 
a different electron acceptor (Cuozzo and Kaiser, 1999; Fraud and Kaiser, 1998). Using 
the yeast S. cerevisiae, Fraud & Kaiser began a genetic dissection of oxidative protein 
folding, managing to isolate EROI (endoplasmic reticulum oxidoreductin 1) which 
encodes a novel but conserved ER membrane protein essential for the net fonnation of 
protein disulfide bonds. Secretory proteins that normally contained disulfide bonds 
remain in the ER in a reduced state in the erol-1 mutant. Introduction of the thiol oxidant 
diamide restored viability in erol mutants, providing evidence that Erolp activity 
introduces oxidising equivalents into the ER via its two pairs of conserved cysteines 
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(Frand and Kaiser, 2000). This was further corroborated by the observation that 
overexpression of EROl confers resistance to otherwise toxic levels of the reductant 
dithiothreitol (DTT), a phenotype distinct from that of PDU overexpression. 
Further investigation by Frand and Kaiser in 1999 led to the suggestion that Erolp is 
responsible for the reoxidation of PDI (Frand and Kaiser, 1999). Direct interaction 
between the two ER-resident proteins was indicated by the isolation of mixed disulfides 
between Erolp and Pdilp, representing intermediates in the transfer of disulfide bonds 
from Erolp to Pdilp. This data suggested that oxidising equivalents are directly 
transferred from Erolp to Pdilp, sustaining Pdilp predominantly in its disulfide form. 
This of course parallels the prokaryotic pathway of oxidative folding, where DsbB serves 
to reoxidise DsbA, the primary oxidant of substrate proteins in E. coli (Missiakas et al., 
1993). In the absence of PDI, Erolp-mediated oxidative folding still takes place, only at a 
slower pace, possibly via interactions of Erolp with other electron acceptors such as 
GSSG, Mpdlp or Mpd2p. Frand & Kaiser's model or Erolp-mediated oxidative protein 
folding can be seen in figure 6. 
This central paper however, failed to answer an important and obvious question; how is 
Erolp reoxidised? Studies with E. coli have shown that the reoxidation of DsbB occurs 
primarily via the transfer of electrons to molecular oxygen at the later stages of the 
respiratory electron transport chain via cytochrome bd or bo oxidase (Kobayashi and Ito, 
1999; Kobayashi et al., 1997). 
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Figure 6. Crysta l s t ructure of Ero1p. Ero lp crystal structure with a-helices represented as cylinders 
(grey) and b-sheets as arrows (red). Secondary structural elements are numbered. Cysteine residues are 
labelled with the active site cysteines nearest FAD in bold. 
Ero1 p crystal structure data taken from (Gross ef at, 2004). 
This is not the case for Erolp; in 2002, Tu & Weissman provided evidence that Erolp 
uses a flavin-dependent reaction to pass electrons directly to molecular oxygen, possibly 
generating reactive oxygen species (ROS) that may contribute to oxidative stress (Tu and 
Weissman, 2002). Depletion of riboflavin from the yeast S. cerevisiae results in defective 
oxidative folding and overexpression of FADf which converts flavin mononucleotide 
(FMN) into flavin adenine dinucleotide (FAD), suppresses the temperature sensitivity o f 
the erol-1 mutant (Tu et al., 2000). Together these data suggest that oxidative folding in 
yeast is dependent on levels o f cellular FAD. Erolp itself is a novel FAD-binding protein. 
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providing further evidence that FAD is important in oxidative protein folding. The crystal 
structure of Erolp was recently solved, allowing identification of the FAD binding site 
(Fig. 6). FAD is thought not to be the terminal electron acceptor, since an excess of free 
F A D cannot drive Erolp-catalysed disulfide formation under anaerobic conditions (Tu 
and Weissman, 2002). Further in vitro work showed that Erolp directly consumes 
molecular oxygen, and taken together with the anaerobic data, suggests that molecular 
oxygen rather than FAD is the terminal electron acceptor. 
1.4.2 Human Erol-La and Erol-Lp 
Recently, the human homologs of Erolp have been described, termed Ero l -La and Erol-
Lp . It has been shown that both of these proteins complement the erol-1 yeast mutant 
demonstrating that both human EROs are functional homologs of the S. cerevisiae Erol 
protein. Both proteins contain the conserved C-X-X-C-X-X-C motif involved in 
transferring oxidative equivalents and both are capable of forming mixed disulfide 
intermediates with PDl (Benham et al, 2000; Cabibbo et ai, 2000; Dias-Gunasekara et 
al., 2005; Mezghrani et ai, 2001; Pagani et al., 2000). In Erolp, the A^-terminal and C-
terminal active sites differ in their function. Mutation of either C352 or C355 completely 
inactivated Erolp, preventing oxidation of the Erolp protein itself and implying that this 
pair is required for generation of disulfide bonds. However, mutation of either ClOO or 
C105 largely but not completely inactivated Erolp and impaired the formation of Erolp-
PDI mixed disulfides, implying that the C100/C105 pair is involved in disulfide transfer 
to PDl. Figure 7 is a cartoon representing the thiol-disulfide exchange pathway of 
electrons from substrate to terminal electron acceptor. 
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E r o l - L a and Ero l -Lp accelerate the generation of disulfide bonds, iiovvever, the absence 
of any human ERO (hERO)-substrate mixed disulfides suggests that, as postulated for 
yeast Erolp, their activity is to oxidise PDI. The reasons why humans and mice both 
possess two ERO proteins while the yeast S. cerevisiae possesses just the one is not yet 
ful ly understood. Erol-Lp transcript expression can be induced by inducing ER stress, 
possibly suggesting separate regulation pathways (Pagani et al, 2000). Interestingly, both 
hEROs exhibit differential tissue expression, with Erol-La highly expressed in the 
oesophagus, whilst Erol-Lp being more abundant in the pancreas, stomach, testis and 
pituitary gland, suggesting that human EROs might participate in tissue specific oxidation 
pathways (Dias-Gunasekara et al., 2005; Pagani et al., 2000). 
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1.5 Thesis Aims 
This thesis endeavours to enhance our understanding of oxidative protein folding in the 
mammalian endoplasmic reticulum. With the identification of numerous disulfide 
oxidoreductases and their homologs, a concerted effort is now required to characterise 
these proteins and answer the question: why is there a need for so many different 
oxidoreductases? The recent identification of the EROs has led to a more complete 
understanding of the disulfide bond formation/rearrangement pathway, but still leaves 
many questions unanswered, including the role of FAD in providing oxidising 
equivalents (Tu and Weissman, 2002) and the unusual tissue distribution of the human 
EROs (Cabibbo et ai, 2000; Pagani et ai, 2000). 
Although no co-crystallisation data exists for Erolp and Pdilp, biochemical evidence of 
disulfide-dependent PDI-Erol-La binding has been obtained (Chakravarthi and Bulleid, 
2004; Molteni et c//., 2004) and also very recently interactions between both PDl and the 
PDl homolog ERp44 with Erol-Lp have been characterised (Dias-Gunasekara et al., 
2005; Mezghrani et al., 2001; Otsu et al, 2006). The recent discovery of the formation of 
hERO homodimers (Dias-Gunasekara et al., 2005) raises important questions about the 
role of hEROs in disulfide bond formation and shows us that the mammalian ER 
oxidation machinery is more complex than anticipated. This work aims to develop an 
understanding of hERO-hERO and hERO-PDI interactions, focusing particularly on the 
G252S and H254Y mutations in the hERO FAD-binding site. 
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The use of specific antibodies to study protein interactions is well documented. It is 
essential that antibodies recognise only the target protein the antibody was raised against. 
When using antibodies to study protein interactions, it is imperative that the antibodies 
are fully characterised, identifying any cross-reactivity and background signals as well as 
confirming recognition of the target protein. Our current anti-peptide polyclonal anti-
Erol-Lp antibody is unable to immunoprecipitate Erol-Lp. Since co-
immunoprecipitation is a powerful tool in elucidating protein interactions, an antibody 
that wi l l immunoprecipitate Erol-Lp will prove helpful in these studies. This work helps 
characterise a polyclonal antibody raised against a recombinant, truncated human E r o l -
LP. 
In 1997, work by Desilva and colleagues led to the isolation of the pancreatic 
oxidoreductase pancreatic protein disulfide isomerase PDlp (Desilva et al., 1997). PDIp 
shares around 46% identity with PDI as well as identical domain organisation (Desilva et 
ah, 1996). Since its initial characterisation, it has been speculated that PDIp is required 
for the folding of pancreas-specific proteins like zymogen, although this has not yet been 
substantiated by experimentation. PDIp has, however, been shown to bind misfolded 
RNase A and zymogen-derived peptides (Klappa et al., 1998b). The interactions of PDIp 
with the endoplasmic reticulum oxidoreductins alpha and beta have yet to be 
characterised. This work investigates the interactions of hEROs with PDI and its 
homologue PDIp. 
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Finally, this work also aims to study the relationship between the UPR and the ER 
folding machinery, using the overexpression of the major histocompatability complex 
(MHC) class I molecule, HLA-B27, as a model. 
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2. Materials and Methods 
2.1 Cell Lilies, Tissues and Antibodies 
Rat pancreatic AR42J cells and human pancreatic Panel cells were maintained in 
Dulbecco's modified Eagle's medium (D-MEM) (Invitrogen), human cervical carcinoma 
HeLa cells were maintained in minimum essential medium (MEM) (Invitrogen), human 
lymphoblastoid, W E W A K l , JESTHOM, HOM-2 (all f rom ECACC) and the human 
monocyte THPl (a gift from J. Robinson, Newcastle University, UK) cells were 
maintained in RPMl 1640 (Invitrogen). A l l cell lines were supplemented with 8 % foetal 
calf serum (FCS) (Sigma) (except AR42J which received 10% FCS), 2 mM Glutamax, 
100 units ml"' penicillin and 100 |^ 1 ml"' streptomycin (Invitrogen) and propagated at 37 
under 5 % CO?. Sterile cell culture passage took place every 2-4 days. Pancreatic 
tissue was obtained from C D l mice. 
The polyclonal rabbit antisera against PDl (Benham et al., 2000), Erol-La (D5) 
(Mezghrani et al., 2001) and Erol-L(3 (Dias-Gunasekara et al., 2005) have been 
described. The mouse monoclonal antibody HA-7 (Sigma) and the anti-myc monoclonal 
antibody 9B11 (Cell Signalling) were both commercially available. The HCIO 
monoclonal antibody was a gift from J. Neefjes, Netherlands Cancer Institute. The 
Netherlands. The rabbit polyclonal anti-PDlp antibody was a gift from M . S. Lan, 
Children's Hospital New Orleans, USA. 
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2.2 Constructs 
The cDNA encoding HLA-B27*05 (verified by DNA sequencing) was a gift from J. 
Neetjes (Netherlands Cancer Institute, The Netherlands). The cDNA encoding PDIp 
(verified by DNA sequencing) was a gift from M . S. Lan, Children's Hospital New 
Orleans, USA. The wild-type pcDNA3Erol-Lp-HA and pcDNA3Erol-Lp-myc 
constructs were a gift from R. Sifia, San Raffaele Del Monte Tabor Foundation, Milan, 
Italy. The Erol-LpG252S and Erol-LpH254Y mutant constructs have been described 
(Dias-Gunasekara et al., 2006). The pcDNA3PDlLT-myc construct has been described 
(van Lith et al, 2005). 
2.3 Digestion and Ligatioti 
Constructs and vectors were restriction digested for 2 h at 37 °C and subsequently 
analysed by on a 1 % agai-ose gel. D N A was cut from the gel and purified using the gel 
extraction kit (Qiagen). Purified D N A was run on a 1 % agarose gel with standard 
concentration of DNA. Concentration of purified DNA was estimated using the pixel 
definition programme T I N A 2.0. Ligation was performed at room temperature for either 
2 h or overnight with T4 D N A ligase (Promega) using various vector:insert ratios. DH5a 
was subsequently transformed with post-incubation ligafion reactions and plated. 
2.4 Cell Transfection 
Sub-confluent HeLa cells in 6-cm dishes were washed with HBSS (Invitrogen) and 
op t iMEM (Invitrogen) serum-free medium. Cell transfection was performed with 
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l ipofectAMINE 2000 (Invitrogen) according to manufacturer's instructions. Cells were 
transfected with 1 |.ig DNA for 6 h in the presence of optiMEM. Post-incubation, cells 
were washed with optiMEM and HBSS and replaced with complete medium. Cells were 
then lysed for analysis 24 h post-transfection. 
2.5 Cell Lysis 
Post-transfection cells or mouse tissue were lysed for protein analysis at 4 "C in 200 |al 
M N T lysis buffer (1 % Triton X-100, 30 m M Tris-HCI, 100 m M NaCI, 20 m M MES, pH 
7.4) supplemented with 20 m M A^-ethylmaleimide (NEM) and 10 f.ig ml ' protease 
inhibitors chymostatin, leupeptin, antipain and pepstatin A (Sigma). Alternatively, cells 
were lysed in 1 ml/10 cm' TRI-reagent (Sigma) for RNA isolation and subsequent RT-
PCR. 
2.6 Cell treatments 
Cells were grown to a density of -2-10 x 10^ cells/ml (calculated using a 
haemocytometer). T H P l , HOM-2, and JESTHOM cells were then plated at a 1:2 dilution 
with fresh RPMI 1640 (Invitrogen). 10 m M DTT or 10 ng ml"' tunicamycin (Sigma) was 
added to induce ER stress. Treatments were staggered in order to achieve the desired 
course of treatment and then subjected to M N T lysis or lysis in tri reagent for RNA 
analysis. 250 tri reagent was added to cells and vortexed. Lysed cells were stored at -
20 °C for RNA extraction according to the manufacturer's protocol. HeLa cells were 
washed with PBS and replaced with fresh M E M (Invitrogen) supplemented with 10 mM 
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DTT (Sigma) for 6 h. Cells were then washed with PBS and lysed in 389 pi tri reagent 
for RNA extraction according to the manufacturer's protocol. THPl cells were grown up 
and plated at 1:2 with fresh RPMl 1640. Cells were treated with 20 pg ml ' 
lipopolysaccharide to induce differentiation to macrophages. Treatments were staggered 
in order to achieve the desired time course. Cells were then lysed in 250 pi tri reagent for 
subsequent R N A extraction according to manufacturer's protocol. 
2.7 RNA Isolation and RT-PCR 
Total RNA from cell lines was extracted using Tri reagent (Sigma) according to the 
manufacturer's protocol. The concentration of extracted RNA was determined by 
spectrophotometry and diluted to 50 ng pi '. 50 ng total cell RNA was subjected to 
reverse transcriptase polymerase chain reaction (RT-PCR) using the AccessQuick RT-
PCR kit (Promega). Primers for X B P l and P-actin were used to detect the relative 
expression of these mRNAs. The RT-PCR cycle used was: Ih 45 °C, T 94 °C, (30" 94 
"C, r 60 °C, r 72 °C) 30x, 5' 72 °C, 4 "C oo. XBPl cDNA was then subjected to Pstl 
digest. A l l cDNA was either run on 1 % or 2 % agarose gel, as indicated, at 100 mV for 
-50 min before exposure to UV light. 
2.8 Pstl Digestion 
Amplified X B P l cDNA was subjected to Pstl digest to detect the presence of spliced 
mRNA. I f not loaded on a gel to check for signal total RT-PCR product (or total PGR 
product minus 5 pi i f X B P l RT-PCR product was loaded beforehand) was digested using 
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1 |.d enzyme in a total volume of 15 | . i l . Digests were for 2 h at 37 "C and then DNA was 
extracted f rom the restriction digest using the PCR purification kit (Qiagen) according to 
the manufacturer's protocol. Extracted digested D N A was then run on 2% agarose gel to 
visualise the digested and undigested DNA. 
2.9 Immunoprecipitation 
Immunoprecipitations were carried out with post-nuclear total cell lysates using 0.5 ^1 of 
anti-HA or anti-myc, 8 |iil of anti-PDI or rabbit bleed antiserum immobilised on 50 \x\ of a 
20 % suspension of Protein A sepharose beads. Immunoprecipitations were performed on 
a rotator for 2 h at 4 °C Beads were then washed twice with lysis buffer before antibody 
was liberated by boiling. Immunoprecipitating proteins were analysed by SDS-PAGE and 
Western blotting. 
2.10 In vitro transcription and translation 
In vitro transcription of pcDNA3Erol-La-myc and pcDNA3Erol-LP-myc constructs 
were performed using 5 | ig of DNA linearised with Eagl, pBluescriptllPDIp was 
linearised with Xbal, pcDNA3PDILT-myc was linearised with Mlul and 
pBluescriptllPDI was linearised with Xbal. T7 RNA polymerase-driven transcription 
reactions were performed using the Promega riboprobe system according to the 
manufacturer's protocol. 2 |ag RNA was translated using the Flexi rabbit reticulocyte 
lysate (Promega) according to the manufacturer's protocol. Proteins we either translated 
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on their own or co-translated. Translations were subsequently analysed by SDS-PAGE 
and Western blotting. 
2.11 SDS-PAGE 
Samples were prepared for SDS-PAGE separation by the addition of 2x loading buffer in 
the presence or absence of 50 m M dithiothreitol (DTT) (Sigma), boiled for 5 min at 95 °C 
and spun down at 4 °C. A l l Blue Precision Plus protein standard (250-10 kD) (BioRad) 
was used as a protein marker. Samples were run on 8 % SDS-PAGE gels for -50 min at 
15 mV in Ix Tris-Glycine SDS buffer (Sigma) in order to resolve all proteins. PVDF 
transfer membranes (Millipore) were prepared for transfer in methanol and washed in Ix 
transfer buffer. Gels were then wet transfeiTed in Ix transfer buffer for 2 h at 30 mV. 
Membranes were then block in 8 % milk in PBST (100 ml dm ' PBS, with 0 .1% Tween 
20 (Sigma)) for 60 min. 
2.12 Western Blotting 
Membranes were incubated with either HCIO (1:200), anti-PDI (1:1000), anfi-Erol-La 
(D5) (1:500), anfi-Erol-Lp (1:50), anti-HA (1:2000), anfi-myc (1:4000) or anfi-PDIp 
(1:800) anfibodies for 60 min before being washed five times with PBST. Membranes 
were then incubated with the corresponding secondary antibody (DAKO) (anti-mouse for 
HCIO, anti-myc and anti-HA and anti-rabbit for anfi-PDI, anti-Erol-La, anfi-Erol-LP 
and anti-PDIp) at 1:3000 for 60 min then subsequently washed five times with PBST. 
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Proteins were then visualised with 200 |.d enhanced chemiluminescence fluid 
(Amersham) and exposed to f i lm (Kodak). 
2.13 Insulin Reduction Assay 
The incubation mixture contained 0.18 mM insulin (Sigma) and various concentrations of 
dithiothreitol (DTT) (Sigma) purified PDI, purified Ero l -Lp , Flavin adenine dinucleotide 
(FAD) (Sigma) or bovine serum albumin (BSA) (Sigma). Reactions were made up to 75 
l-il using phonate buffered saline (PBS) (Sigma). Samples were placed in a UVette 
(Eppendorf) at room temperature or at 37 ''C for the indicated time. Turbidity was 
analysed at 600 nm using a spectrophotometer (Eppendorf)-
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3.1 The role of FAD in the interactions and function of Erol-Lp 
3.1.1 Introduction 
Recent genetic and biochemical studies have led to the identification of essential 
components of the eukaryotic oxidative protein folding machinery. The conserved ER-
resident protein Erolp is required for oxidative protein folding since compromised Ero lp 
function results in sensitivity to the reductant DTT and the accumulation of the reduced 
forms of PDI and substrate proteins (Frand and Kaiser, 1998; Pollard et al., 1998). This 
phenotype mimics that resulting from the loss of the bacterial redox enzyme DsbB 
(Bardwell et al., 1993). Erolp is a membrane-associated flavoprotein able to generate 
disulfide bonds and transfer them to PDI which then direcdy catalyses disulfide 
formation in substrate proteins (Frand and Kaiser, 1999; Tu et al., 2000). Thus, Erolp 
acts as the source of oxidising equivalents for PDI-mediated oxidative substrate folding. 
Overexpression of FADl, which converts flavin mononucleotide (FMN) to flavin adenine 
dinucleotide (FAD) was able to suppress the temperature sensitivity of the erol-1 mutant 
indicating that oxidative folding in yeast is dependent on levels of free FAD (Tu et al., 
2000). An in vitro model was constructed with purified components to test this theory and 
it was subsequently found that reactivation of denatured and reduced RNase A depends 
on the presence of PDI, EROl and oxidised flavin adenine dinucleotide (FAD) (Tu and 
Weissman, 2002). Under anaerobic conditions, free FAD alone is insufficient to drive 
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Erolp-mediated disulfide formation and thus is not an efficient terminal oxidant for 
Erolp (Tu and Weissman, 2002). Using an oxygen consumption assay, Tu and Weissman 
were able to show that in the presence of free FAD, Erolp can couple its reoxidation 
directly to the reduction of O2 (Tu and Weissman, 2002). Thus, Erolp is able to harness 
the oxidising potential of molecular oxygen for the formation of disulfide bonds. 
The high sensitivity of Erolp to levels of free FAD is unusual since most flavoproteins 
contain tightly bound flavin cofactors. It has since been suggested that a cofactor relay 
system may exist where tightly bound FAD could pass electrons onto imbound FAD, 
which could then deliver them to a terminal electron acceptor. Sensitivity to free FAD 
could provide an important mechanism by which to regulate oxidative folding by 
coupling protein oxidation to folding load and/or the metabolic status of the ce l l since 
FAD transport into the ER is a prerequisite for its oxidative effect (Papp et ai, 2005; Tu 
and Weissman, 2002). Given that a standard two-electron reduction of molecular oxygen 
produces hydrogen peroxide (H2O2), uncontrolled levels of Erolp oxidase activity could 
lead to the production of reactive oxygen species (ROS), an over-oxidised ER and/or 
protein misfolding (Tu and Weissman, 2004). Regulation at the level of production of 
oxidising equivalents would potentially allow for efficient management of total oxidative 
folding in the ER. Interestingly, RIBl, the enzyme responsible for the first steps of 
riboflavin biosynthesis, is itself a target of the unfolded protein response (UPR) (Travels 
etal.,2000). 
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Despite genetic and biociiemical approaches confirming the essential components of 
Erolp-mediatecl oxidative folding, it was not until 2004 that the mechanism by which 
FAD passes oxidising equivalents to Erolp began to be elucidated. Gross and colleagues 
published the crystal structure of FAD-bound Ero lp in 2004 revealing the molecular 
details of the catalytic centre and the relationship between the functionally significant 
cysteines and the bound cofactor (Gross et ciL, 2004). Erolp is predominantly a-helical 
with five short P-sheets and two extended loops (Fig. lA). The position of the 
catalytically active C-X-X-C domain at Cys"^ ^ -^Cys^ ^^ and Cys'"°-Cys'°^ coiToborates data 
from Frand & Kaiser in which PDl interacts with, and passes electrons to, Erolp via its 
Cys"'°-Cys"''^ active site which in turn transfers them internally to Cys'^^-Cys''^^ (Frand 
and Kaiser, 2000). Further crystallographic evidence confirms the presence of a disulfide 
relay where Cys"^° and Cys'°' ' are located on a flexible loop capable of changing 
conformation by 17A bringing Cys'"^ within disulfide-bonding distance of Cys"* "^. 
Interestingly, the Cys'^^^-Cys''^'' disulfide is positioned adjacent to the FAD cofactor 
allowing this disulfide to be readily oxidised via FAD interaction (Fig 15). Thus, 
electrons are transferred from a folding substrate to the catalytic active site of PDI to the 
Cys"'"-Cys'°^ disulfide of Erolp, intramolecularly to the Cys'* '^'-Cys''"^^ disulfide and then 
onto the bound FAD cofactor which may then transfer electrons to the pool of unbound 
FAD. 
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Figure 1 . Crys ta l s t ructure of Ero1p. /A, Ero1p crystal structure witti a-tielices represented as 
cylinders (grey) and p-sheets as arrows (red). Secondary structural elements are numbered. S, Ttie same 
view as in A is stiown. Cysteine residues are labelled with ttie active site cysteines nearest FAD in bold. 
Ero1 p crystal structure data taken from (Gross ef a/., 2004). 
Erolp shows structural similarity to the yeast sulfhydryl oxidase Erv2p despite sharing 
little or no sequence homology. Both molecules contain active site cysteine pairs in a C-
X-X-C motif adjacent to the isoalloxazine ring o f a bound FAD molecule. Four of the 
eight a-helices o f Erolp can be superimposed onto the helical bundle o f Erv2p. However, 
the order o f the helices in the primary structure is different (Gross et ah, 2004). These 
two molecules differ in the way that electrons might exit FAD. Ervlp possesses a short 
clear channel leading directly to the N5 nitrogen lined with hydrophobic residues. Erolp 
however, possesses no such channel and FAD is in fact buried within the Erolp molecule 
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unavailable for molecular oxygen, or any other terminal electron acceptor, to gain access 
to the isoalloxazine ring of the bound FAD. This difference is reflected in their 
behaviour, with Erv2p restricted to using molecular oxygen as a terminal electron 
acceptor whilst Erolp has been shown to be use other terminal electron acceptors under 
anaerobic conditions (Cuozzo and Kaiser, 1999). 
The lethal temperature-dependent erol-1 mutant and the erol-2 mutant, which shows 
hypersensitivity to the reducing agent DTT, are both the result of a two separate single 
substitutions within the Ero flavin fold (Fraud and Kaiser, 1998; Pollard et a/., 1998). The 
erol-1 mutation is a G229S substitution in Erolp which is equivalent to Gly'^ ^^ in the 
human ERO (hERO) Erol-L|3. The erol-2 mutation is H 2 3 I Y which is equivalent to 
His'^"* in Erol-L(3. The remaining six points of contact between Erolp and FAD are 
conserved in Erol-La and Erol -Lp. The phenotypes of these mutants are most likely due 
to an inteiTuption in the binding of FAD to Erolp leading to a loss of function. Mutated 
FAD-binding motifs could potentially result in an unstably bound FAD or result in bound 
FAD being at a position when it is unable to react with the catalytic Cys"'^'-Cys''^^ 
disulfide. Thus, erol mutants may prevent electron transfer. The aim of this work is to 
biochemically characterise erol mutant interactions to further understand the role of FAD 
in oxidative protein folding. 
The work in this chapter was carried out in parallel to the publication of Dias-Gunasekara 
and colleagues' work of 2005 and 2006 and accordingly contains data that relates to this 
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published work (Dias-Gunasekara et al., 2005: Dias-Gunasekara et a/., 2006). Any 
conclusions derived from data leading directly to those publications during the course of 
my work are not referenced and are instead referred to as observations by the group. 
Some observations referred to as 'data not shown' are now published in the 
aforementioned articles. 
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3.1.2 Resul ts 
3.1.2.1 Ewl-Lfi forms homodiiners in vivo 
Both Erol-La and Erol-Lp have been shown to form mixed disulfides with PDI, 
corroborating their role in providing oxidizing equivalents for disulfide bond formation in 
vivo (Cabibbo et al, 2000; Mezghrani er al., 2001). The presence of disulfide-dependent 
complexes in Erol-Lp C-X-X-C-X-X-C mutants that scarcely interacted with PDI (Data 
not shown) led to the speculation that Erol-LP might form homodimers, especially as 
other members of the thioredoxin-like family can exist as homodimers (Liepinsh et al., 
2001). The formation of human Ero homodimers has also been postulated by others 
(Mezghrani et ai., 2001). 
To investigate the hoinodimerisation of Ero 1-LP and the formation of disulfide-
dependent high-molecular weight complexes, two differentially tagged Erol-LP proteins 
were constructed. A triple-tagged Erol-LP-myc protein and a single-tagged Erol-LP-HA 
(haemagglutinin) protein enable monomelic forms of the protein to be visible as two 
distinct bands on SDS-PAGE separation due to the different tag size (Fig. 2A). Other 
groups have shown that myc- and HA-tagged human Eros reside within the ER and are 
functionally comparable to their non-tagged equivalents (Anelli et al., 2002; van Lith et 
al., 2005) (S. Dias-Gunasekara and A . M . Benham, unpublished data). 
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Under non-reducing conditions, disulfide-dependent high molecular weight complexes 
are visible as a distinct band or a number or bands migrating higher up in the gel. Hence, 
transfected lysates were examined by SDS-PAGE in the absence of DTT, Western 
blotting for the Erol-L(3-myc using the a-myc mAb (Fig. 25). The original lysates were 
generated by lysing in the presence of the alkylating agent iV-Ethylmaleimide (NEM) 
which traps free cysteines. The use of an alkylating agent when studying disulfide-linked 
complexes in vivo also prevents the formation of post-lysis complexes. Monomeric E r o l -
LP-myc was detected lower down in the gel (Fig. 2B, lanes 1 and 3). As expected, no 
HA-tagged Erol-Lp was detected. High-molecular weight complexes were detected in 
the WT-myc and WT-myc/WT-HA transfected lanes (Fig. 25, lanes 1 and 3) and 
represented disulfide-dependent complexes. 
In order to further investigate the components of the disulfide-dependent complexes seen 
in Figure 25, lysates were prepared as before, transfecting HeLa cells with wild-type 
Erol-Lp either myc-tagged, HA-tagged or transfecting with both. Again, lysates were 
resolved on SDS-PAGE but this time membranes were immunoblotted with monoclonal 
antibodies to both tagged proteins (a-HA and a-myc) (Fig. 3i4). Extensive high-
molecular weight complexes were detected, as well as the monomeric form of Erol-LP 
(Fig. 3A, lanes 1-3). The anti-myc and the anti-HA antibodies differed in their success at 
recognizing tagged Erol-LP in non-reducing gels, as seen with the levels of monomeric 
Erol-Lp detected (Fig. 3/4, compare lanes 1 and 3 with lane 2). This has also been 
observed by other investigations in our group (data not shown). 
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Figure 2. Ero1-Lp fo rms disul f ide-dependent c o m p l e x e s in vivo. A, Reducing gel (R) showing distinct 
migration of differentially tagged wild-type (WT) Ero1-Lp. HeLa cells were subjected to liposonne-mediated 
transfection of either a myc-tagged Ero1-L(i (lane 1), HA-tagged Ero1-Lp (lane 2), or myc- and HA-tagged double 
transfected Ero1-Lp (lane 3) or mock transfected (lane 4) which were separated by SDS-PAGE and 
immunoblotted for using the a-Erop pAb. (vlyc-tagged (U) and HA-tagged (H) Ero1-Lp are indicated. 6, The same 
HeLa transfectants, lysed in the presence of NEM, were analysed under non-reducing conditions in order to 
preserve any disulfide-dependent complexes. t\/lonomeric Ero1-Lp {*) was detected using a-myc (lanes 1 and 3) 
and high-molecular weight complexes are visible -150 kD in these lanes (S-S). 
Results Chapter 1 53 
Complexes were more abundant in the double transfected sample (Fig. 3A. lane 3) where 
three distinct bands were detected. The uppermost and lowermost bands seen in the 
double transfected lysate correspond to high-molecular weight bands seen in the WT-myc 
transfected and WT-HA transfected samples respectively. These distinct bands are the 
result of myc-tagged homodimers (Fig. 3A, lane 1) and HA-tagged homodimers (Fig. 3/4, 
lane 2). The middlemost band seen in the double transfected lysate is the result of 
homodimerisation of a myc- and an HA-tagged Erol-Lp. 
To confirm an Ero-Ero interaction, HeLa cells were transfected as before and lysed in the 
presence of NEM. Lysates were subjected to immunoprecipitation with Protein A 
Sepharose beads. Immunoprecipitation involves the interaction of a protein of interest 
with an antibody conjugated to a Protein A bead (Fig. 3B). We took advantage of the 
differently tagged Erol-Lp molecules by conjugating the anti-myc antibody to Protein A 
sepharose beads to isolate the myc-tagged Ero 1-LP in the transfected lysates. Once 
isolated, immunoprecipitates were taken up in loading buffer and separated by SDS-
PAGE. To determine i f Erol-LP-HA indeed interacted (co-immunoprecipitated) with 
Erol-LP-myc, the membrane was immunoblotted with anti-HA (Fig. 3C). Erol-LP-HA 
was detected in the double transfected lysate, indicating that it had been pulled down with 
the anti-myc antibody via interaction with the myc-tagged EroI-LP (Fig. 3C, lane 3). As 
expected, no signal, except antibody bands, was detected in the single transfected samples 
since Erol-LP-HA was not pulled down by the protein A-conjugated anti-myc and the 
transfected Erol-LP-myc was not recognized by immunoblotting with anti-HA. As a 
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control, non-IP samples were blotted for PDI showing comparable levels of protein in the 
lysates used (Fig. 3D). Taken together, (with the work of Dias-Gunasekara and 
colleagues) these data show that Erol-Lp is capable of forming extensive disulfide-
dependent complexes. A major component of these complexes is disulfide-dependent 
Erol-LP homodimers. 
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Figure 3. Ero1-L(3 is capable of forming homodimers . A, HeLa cells were transfected withi eittier 
Erol-Lp-myc (WT-myc) (lane 1), Ero1-Lp-HA (WT-HA) (lane 2), double transfected with both Ero1-Lp-myc 
and Ero1-Lp-HA (WT-myc/WT-HA) (lane 3) or mock transfected (lane 4). Proteins were lysed in the 
presence of NEM and resolved on a non-reducing (IMP) SDS-PAGE gel before being subject to 
immunoblotting with using anti-myc and anti-HA. High-molecular weight complexes were resolved in all 
transfected lysates (compare lanes 1-3 with lane 4). A distinct band in lanes 1 and 3 was resolved 
corresponding to a WT-myc homodimer (l\/l+M). Equally, a distinct band was seen in lanes 2 and 3 
corresponding to a WT-HA homodimer (H+H). The WT-myc-WT-HA homodimer (M+H) was only observed in 
the double transfected sample (lane 3). S, Lysates of single and double tagged transfectants were obtained 
as in A. Immunoprecipitation was performed using the anti-myc antibody and immunoblotting with the anti-
HA mAb. Anti-myc antibody heavy chain (HC) can be seen in all four IP samples migrating as a distinct band 
at -50 kD (lanes 1-4). Ero1-Lp-HA was detected (lane 3) after IP with the anti-myc mAb indicating an in vivo 
interaction between Ero1-Lp -myc and Ero1-Lp-HA.C, A protein A sepharose bead is conjugated to an 
antibody during incubation. Proteins in a cell lysate, for example, are isolated using an antibody specific for 
that protein. The mixture is then centrifuged and the supernatant removed isolating the target protein, and 
any associated molecules, for further analysis. D, The same lysates used for the IP in B, were subjected to 
reducing (R) SDS-PAGE and immunoblotting with the pAb anti-PDI as a positive control for transfection. 
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3.1.2.2 Mutations in the FAD-binding site of Erol-Lfi diminish, but do not 
prevent interaction with PDI 
We next investigated the biochemical properties of the Erol-LP equivalent of the 
temperature sensitive mutant erol-1 and the DTT-hypersensitive mutant erol-2. Ero lp 
and Erol-LP share conserved FAD binding residues (Fig. 4). We therefore engineered 
point mutations in Erol -Lp that corresponded to the erol mutations. Site-directed 
mutagenesis was employed to produce myc-tagged Erol-LpG252S and Erol-LpH254Y 
mutants for functional analysis. 
Firstly, expression of both mutant constructs was verified by transfection into HeLa cells. 
Tagged constructs were then immunoblotted with anti-Erol-Lp and anti-myc (Fig. 5A 
and B). Anti-Erol-Lp antibody recognised both wild-type Erol-Lp and the H254Y 
mutant (Fig. 5A, lanes 1 and 2). However, recognition of Erol-LP G252S was relatively 
low (Fig. 5A, coinpare lanes 1 and 2 with lane 3). This is likely due to transfection 
efficiency or loading. Both mutants were constructed with C-terminal triple myc tags. 
Mutations in the FAD-binding domain of Erol-LP should not affect their recognition by 
the anti-inyc antibody since that epitope is located at the C-terminus of the protein. 
Wild-type and mutant Erol-LP transfected lysates were resolved by non-reducing SDS-
PAGE, transferred to nitrocellulose and subjected to immunoblotting using the anti-myc 
antibody (Fig. 5B). Both wild-type and mutant monomelic Erol-Lp was resolved at equal 
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intensity (Fig. 5B. lanes 1-3) suggesting that stability of Erol-L(3 was not compromised 
by G252S or H254Y mutations. By subjecting transfected lysates to non-reducing SDS-
PAGE, we were also able to resolve a collection of trapped high-molecular weight 
species presumably composed of covalently interacting proteins (Fig. 5S, lanes 1-3). 
PDI is a component of wild-type Erol-L|3 complexes (Cabibbo et al., 2000; Mezghrani et 
ciL. 2001). We investigated the binding of Erol-LP FAD-binding mutants with PDI in 
order to a) identify a component of the high molecular weight complexes fornied under 
non-reducing conditions (Fig. 5B) and b) investigate the effect of point mutations in the 
FAD-binding site of Erol-LP on association with its electron donor PDI. 
Under non-reducing conditions both G252S and H254Y not only ran as a monomer but as 
a collection high-molecular weight complexes (Fig. 5B, lanes 2 and 3). Both mutant and 
wild-type lysates were then analysed for co-immunoprecipitation with the anti-PDI 
antisera (Fig. 5C and D). Both mutants specifically co-immunoprecipitated with PDI but 
to a lesser extent than wild-type Erol-Lp (Fig. 5C, compare lanes 2 and 3 with lane 1 and 
Fig. 5D, compare lanes 2 and 3 with lane 1). High-molecular weight co-
immunoprecipitation complexes are visible in the non-reduced SDS-PAGE gel after anti-
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Figure 4. Po in ts of contact between flavin adenine dinucleot ide (FAD) and yeast E r o l p . 
A, The FAD cofactor is held between helices a2 and a3 with the isoalloxazine and adenine rings buried 
in the protein. Ero lp makes a variety of contacts with FAD. Dashed lines indicate putative hydrogen 
bonds or salt bridges while double headed arrows represent stacking interactions between amino acid 
side chains and ring systems in the FAD. S, Residues involved in aromatic ring stacking are further 
illustrated in this ball and stick diagram. Residues are numbered based on the full length Ero lp 
sequence. C, Ero lp and human Erol-Lp protein sequence alignment showing the level of conserved 
residues. The ero1-1 and ero1-2 mutations Erolp G229S and H231Y correspond to G252S and H254Y 
in Ero1-L(i. Ero lp crystal structure data taken from (Gross et al., 2004). 
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PDI immunoprecipitation (Fig. 5D, lanes 1-3). These complexes represent NEM-
dependent, covalent, disulfide-dependent Erol-LP-PDl dimers. The G252S mutant in 
particular, showed little association with PDI in the non-reducing gel compared to wild-
type Erol-Lp and the mock sample suggesting that mutations in the FAD-binding site 
affected the ability of Ero-LP to disulfide bond with PDI. In the non-reduced gel, H254Y 
complexes resolve to a tight band, albeit less intense than wild-type (Fig. 5D, lane 2). 
Erol-Lp G252S and H254Y, both form non-disulfide-dependent complexes with PDI 
however, association is not as strong as wild-type Erol-Lp-PDI interactions. (Fig. 5C). 
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3.1.2.3 The G252S and H254Y imitants are able to form honiodimers 
Having shown that wild-type Erol-Lp is capable of forming homodimers we were 
interested in seeing i f our FAD-binding mutants were able to dimerise. This would allow 
us to examine whether the erol-1 or eiol-2 phenotypes could be explained by a failure of 
mutant Eros to self complex. The pattern of high-molecular weight complexes in the 
G252S and H254Y mutants was similar to that of the wild-type Fro 1-LP (Fig. 5B, 
compare lanes 2 and 3 with lane 1), suggesting that, like wild-type Erol-Lp, homodimers 
may make up a portion of those complexes. The majority of Erol-LP-PDl interactions are 
covalent (Fig. 5B and D) (Benham et al, 2000; Mezghrani et al., 2001; Pagani et al., 
2000) and occur via cysteine-cysteine interaction. Impaired Erol-LP-PDI interaction 
might suggest that homodimer formation may also be impaired. 
G252S and H254Y mutants with a single haemagglutinin tag were used to study 
interactions with their myc-tagged equivalents. The expression of the HA-tagged proteins 
was studied by single or co-transfection and subsequent anti-Erol-Lp immunoblotting 
after SDS-PAGE gel separation under non-reducing (Fig. 6A) or reducing (Fig. 66) 
conditions. Differentially tagged proteins migrated into two distinct bands, as previously 
demonstrated (Fig. 2A). Expression of mutant-tagged proteins in this instance was 
slightly lower when compared with wild-type (Fig. 6B, compare lanes 1, 2 and 4 with 
lanes 3 and 5). Upon non-reducing analysis, HA-tagged single transfectants were not 
detected either in their monomeric or multimeric forms (Fig. 6A, lanes 2 and 3). This is 
consistent with other results showing that the Erol-UP serum is inefficient at determining 
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Figure 5. E r o l - L p FAD mutants G252Y and H254Y form disulfide-dependent complexes 
despite poor association witli wild-type PDI. A, HeLa cells were transfected with myc-tagged 
wild-type Ero1-Lp (WT) (lane 1), H254Y mutant (lane 2), G252S mutant (lane 3) or mock (lane 4). Post-
nuclear lysates were analysed under reducing conditions (R) and immunoblotted for a-Ero|i. B, lysates 
were obtained as in A but were subjected to non-reducing (NR) SDS-PAGE and immunoblotted with a-
myc to resolve both the monomeric form and the high-molecular weigh complexes. C, D, Lysates were 
prepared as in A and immunoprecipitated with a-PDI. Lysates were then immuniblotted with a-myc to 
detect any co-immunoprecipitating Ero1-L(i under reducing (R) conditions (C) or non-reducing conditions 
(D). 
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non-reduced Erol-L(3 (S. Dias-Gunasekara and A . M . Benham. unpublished data). The 
anti-HA antibody was then used in order to detect high-moiecular weight complexes. 
Post-nuclear lysates were then subjected to imniunoprecipitation using the anti-myc 
antibody, were analysed by SDS-PAGE under non-reducing conditions and 
immunoblotted using the anti-HA antibody (Fig. 6C). No complexes other than 
antibodies were resolved since disulfide bonded antibody bands migi-ate in the same area 
of interest as Ero complexes. In order to resolve this issue, the same co-
immunoprecipitated samples were subjected to reducing SDS-PAGE and immunoblotted 
using the anti-Erol-Lp antibody (Fig. 6D). The anti-Erol-L(3 antibody recognised both 
myc-tagged and HA-tagged Ero 1-LP as expected (Fig 6D, lanes 1-3). Mock and single 
HA-tagged transfectants were not recognised by anti-myc immunoprecipitation and thus, 
were blank when blotted for Erop (Fig. 6D, lanes 4-6). H254Y-HA, G252S-HA and WT-
HA tagged Ero 1-LP clearly co-immunoprecipitated with H254Y-myc, G252S-myc and 
WT-myc respectively (Fig. 6D, lanes 1-3). The co-immunoprecipitation of differentially 
tagged Ero 1-LP suggests that both wild-type and the FAD-binding mutants G252S and 
H254Y are capable of forming homodimers. Thus, point mutations in the FAD-binding 
domain do not prevent self-complexing or the formation of homodimers within the ER. 
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Figure 6. The FAD-binding mutants of Ero1-Lp are able to form homodimers. A, HeLa cells were 
either single (lanes 2 and 3), double transfected (lanes 1 and 4-5) or mock transfected (lane 6) with wild-type 
(WT) (lanes 3 and 4) or mutant (lanes 1,2 and 5) Ero1-Lp. Cells were lysed in the presence of NEM and 
subjected to non reducing (NR) SDS-PAGE in order to resolve monomeric and high-molecular weight 
complexes. Membranes were immunoblotled with the anti-Ero() antibody. 6, Lysafes used in A were subjected 
to reducing (R) SDS-PAGE to disrupt and disulfide bonds and immunoblotted with the anti-Ero|3 antibody. C, 
Lysates were subjected to immunoprecipitation (IP) with the anti-myc mAb using Protein A Sepharose beads. 
Co-immunoprecipitating molecules were then analysed by non-reducing SDS-PAGE and immunoblotted for 
anti-HA in order to visualise the formation of both covalent and non-covalent complexes. D, Lysates subjected 
to the IP in C were analysed under reducing conditions and imunoblofted for Ero1-Lp using the anti-Ero|3 
antibody. 
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3.1.2.4 Assessment of Erol-Lp in an insulin reduction assay 
Next we wished to study the functional activity ot'the purified protein using a closed in 
vitro system mimicking the components of the oxidative folding machinery present in 
vivo. The use of a spectrophotometric insulin assay was pioneered by Luthman in 1979 to 
study mammalian thioredoxin and thioredoxin reductase and was subsequently used by 
the group to study other members of the thioredoxin-like family (Holmgren, 1979; 
Lundstrom and Holmgren, 1990; Luthman and Holmgren, 1982). A simplified version of 
this assay was used to study the activity of purified Erol-L(3. The assay exploits the fact 
that, upon the reduction of insulin by the reductant DTT, intra-chain disulfide bonds in 
insulin are disrupted, leading to precipitation of the protein and an increase in turbidity. 
In a closed system mimicking that of oxidative folding //; vivo, PDl wil l be able to 
recharge DTT by Erol-mediated oxidation leading to the continual reduction of insulin. 
We were interested in seeing what effect Erol -Lp would have on PDl reductase activity 
and to confirm that Erol-LP does not act directly on substrates as an oxidoreductase. 
Firstly, reduction of insulin by DTT was optimised. It was important that levels of 
reduction were not too high prior to the introduction of oxidoreductases since catalysis of 
this reaction could send readings into an unreliable range. Insulin was used at 0.18 mM, a 
concentration within the range of published work (Lundstrom and Holmgren, 1990) and 
the effect of three concentrations of DTT were studied in a volume of 75 |al. Phosphate 
buffered saline (PBS) made up the remainder of the reaction volume and was therefore 
used to blank the OD readings. Readings were taken at 600 nm every 10 minutes for 
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approximately 2 hours at room temperature (Fig. 7/\). As expected, PBS remained at 
baseline absorbance throughout the 180 minutes. A higher concentration of DTT caused 
quicker (ODooo reading of 0.5 after -20 m with 10 m M DTT compared with -35 m with 5 
m M DTT) reduction of insulin and a higher end point (ODf,oo ~2.1 with lOmM DTT 
compared with -1.75 with 5 mM DTT) due to the fact that more insulin was reduced. 
Since our spectrophotometer was accurate within a range of OD^oo -0.2-2.0, the 
absorbance levels were too high. Thus, a concentration of 3 m M DTT was used instead 
(Fig. IB). During this assay, 0.87 \iM of the purified enzyme PDI was introduced to see i f 
it had an effect on insulin reduction. Upon the addition of PDI to the assay, levels of 
reduced insulin began to rise within -20 minutes compared to that of the non-catalysed 
reactions which only showed levels of reduction above baseline after -40 minutes. The 
use of 3 m M DTT produced levels of insulin reduction outside of the accuracy of the 
photospectrometer after 2 hours. However, when compared to the initial experiment, in 
which levels of insulin reduction were seen after -20 minutes (10 m M DTT) and -35 
minutes (5mM DTT) (Fig. 7/\), the use of 3 m M DTT does delay reduction somewhat. 
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Figure 7 . The optimisation of the reduction of insulin by DTT. A, 0 . 1 8 mM insulin was reduceij 
by both 1 0 mM and 5 mM of DTT at room temperature in 7 5 nl P B S . ODeoo rea(dings were taken every 1 0 
m for 2 h. B, Insulin was reduced as in A but using 3 mM DTT and 3 mM DTT with the addition of 0 . 8 7 MM 
purified PDl. 
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Next, a concentration range of DTT at 3 mM, 1 mM and 0.3 mM was used (Fig. 8/1). 
Each concentration of DTT was either uncatalysed or supplemented with PDI at the 
concentration used in the previous assay. The reduction of insulin by DTT varied greatly 
depending on the concentration of DTT in this experiment. The uncatalysed reactions 
using 0.3 m M and 1 m M DTT barely left baseline level. Again, the 3 m M DTT reaction 
caused a high level of reduction with a maximum ODeoo of -1.2 which left the baseline 
level after -30 minutes, slightly faster than the previous experiment. A l l catalysed 
reactions decreased the amount of time needed for the initiation of insulin reduction. 
Furthermore, the initiation of the reaction increased relative to the concentration of DTT 
used. That is to say, reduction increased upon treatment with higher concentrations of 
DTT which further increased upon the addition of a catalytic concentration of PDI. Since 
the aim of this experiment was to optimise the concentration of DTT, the reaction was 
only carried out for 100 minutes; therefore the experiment was terminated before 
maximum absorbance levels were obtained. 
It was decided that, in the interests of assay sensitivity, a concentration of I m M DTT 
would be most appropriate. Next, the concentration of PDI was optimised in order to a) 
keep the assay within a sensitive range and b) to utilise the little purified protein 
efficiently (Fig. 8i?). A reaction was set up where insulin reduction by PDI was 
monitored in the absence of DTT (Fig. SB). PDI had no direct effect on insulin meaning 
any increase in turbidity of insulin upon the addition of PDI requires priming by DTT. By 
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Figure 8. Reduction of insulin by PDI. A, 0.18 mM insulin was reduced by 3 mM, 1 xvM and 0,3 mlVl of 
DTT at room temperature in 75 (.il PBS in the presence or absence of 0.87 i^M PDI. ODeoo readings were taken 
every 10 m for 2 h. B, Insulin was reduced using 1 mlVI DTT in the presence of a range of PDI concentrations 
(0.87 nM, 0.435 M M (1/2) and 0.087 nM (1/10)). 
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lowering the concentration of PDI in the reaction by a factor of 2 or 10, the insulin 
reduction is much slower and becomes more similar to the uncatalysed reaction (Fig. 85). 
In order to obtain results within the appropriate range, optimisation of PDI in the assay 
was essential. By using 0.087 ^iM (1/10 the original concentration of PDI), OD readings 
were below the range required. Using 0.435 ^iM PDI (half the original concentration) left 
readings too high, therefore the next set of reactions utilised 0.218 (iM, or a quarter of the 
original concentration of PDI. Besides using an optimised concentration of PDI, this set 
of reactions introduced purified Erol-LP to the system at equimolar concentration to PDI. 
Any direct effect of Erol-LP on insulin reduction i.e. in the absence of DTT would be 
observed (Fig. 9A). Despite only adding catalytic amounts of protein, we wanted to 
control for an increase in protein content. Non-catalytic bovine albumin serum was used 
in one reaction in place of Ero 1-LP at equimolar concentration as a control. These 
reactions show that Erol-LP has no direct effect on the reduction of insulin since no 
increase in turbidity was detected in the absence of DTT (Fig. 9A). Addition of PDI to the 
reaction increased the rate at which reduction is initiated, as expected. Upon addition of 
Ero 1-LP to this reaction, the rate of insulin reduction is further increased with reduction 
significantly above PDI/DTT catalysed reaction. Interestingly, after 130 minutes both the 
PDI-catalysed and the Erol-Lp/PDI-catalysed reaction showed the same level of 
absorbance. The BSA control showed that Ero 1-LP does not confer its effect merely by 
increasing protein or thiol/disulfide content. 
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Next, we studied the effect of a concentration range of Erol-L(3 on insulin reduction to 
ask i f a decrease in Ero l -Lp concentration lead to a decrease in rate of insulin reduced. 
Erol-Lp was added at one f i f th (0.453 |.iM) and one tenth (0.022 (.iM) the concentration 
used in the set of reactions presented in figure 9A (Fig. 9B). In this experiment, the effect 
of DTT on Erol-Lp/PDI insulin reduction was examined. Since Erol-Lp possesses 
oxidase activity, it is feasible that it may directly oxidise DTT, inhibiting further 
reduction of insulin in a PDI-independent manner. Thus, we investigated whether E r o l -
Lp mimics PDl activity in this assay (Fig. 9B). The reaction involving the components 
insulin, DTT and Erol-LP showed levels of insulin reduction comparable to those using 
just insulin and DTT, suggesting that Erol-LP exerts no direct oxidase activity. However, 
addition of Erol-LP in the presence of PDl in these set of reactions did not increase the 
rate of insulin reduction (Fig. 9B). Conversely, the addition of Erol-LP to these reactions 
seemed to partially inhibit the reduction of insulin since the highest rate of reduction was 
seen in the solely PDI-catalysed reaction suggesting that Erol-LP may be competing for 
DTT with PDl. These data therefore, are contrary to those in Fig. 9A, which suggest that 
addition of Erol-LP to PDI-catalysed reactions increased the rate of insulin reduction. 
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T h e d i r ec t a n d i n d i r e c t e f f e c t o n E r o 1 - L | J o n the r e d u c t i o n of i n s u l i n v i a P D I a n d D T T 
Time (m) 
B T h e r e d u c t i o n of i n s u l i n u s i n g a r a n g e of E r o 1 - L P c o n c e n t r a t i o n s 
Time (m) 
Figure 9. The direct and indirect effect of Ero1-Lp on insulin reduction. A, Insulin was 
reduced as in previous assays but with the addition of both Ero and P D I where D T T was not added in 
order to examine their direct effect. Ero1-Lp was added into reactions using a concentration range of 
0.318 nM, 0.0635 \M (1/5) and 0.0318 \M (1/10) in order to study the effects of Ero1-Lp activity. 
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T h e r e d u c t i o n of i n s u l i n u s i n g a r a n g e of E r o 1 - L | l c o n c e n t r a t i o n s 
- P B S 
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DTT + INS+ PDI + 1/10 ERO 
DTT + INS + P D I + 1/10 ERO 
D T T + I N S + P D I + 1 /10ERO 
Time (m) 
Figure 10. The effect of a range of FAD concentrations on Ero1-Lp-mediated insulin 
reduction. A, A range of Ero1-L|S concentrations was studied as in Fig. 96. S, The addition of an equimolar 
concentration of FAD (1x) and in excess (1.5x) aimed to study the effects of FAD on Erol-L(5-mediated 
oxidative folding. 
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In order to obtain a definitive answer to whether or not our purified Ero l -Lp influenced 
the rate of insulin reduction, the set of reactions presented in figure 9B was repeated, 
minus the control for the direct effect of Erol -Lp on DTT (Fig. lOA). Again, the solely 
PDI-catalysed reaction and the addition of both concentrations of Ero l -Lp to this reaction 
mixture all exhibited insulin reduction. In this case however, the addition of Erol-LP at 
0.0218 f.iM (one tenth the concentration of PDI in the reaction), lead to a sinall increase in 
rate of reduction. In opposition to this, the addition of a higher concentration on Erol-Lp 
resulted in a level of insulin reduction slightly lower than that of the uncatalysed reaction. 
Overall, we concluded that addition of Ero l -Lp has limited or no effect on the rate of PDI 
catalysed insulin reduction. 
Since Ero l -Lp is a flavoprotein, we supplemented our reaction with commercial flavin 
adenine dinucleotide (FAD). The addition of FAD to the reaction mixture would 
complete all the components deemed necessary for oxidative folding (Tu et «/., 2000). 
FAD was introduced at 0.022 \jlM (equimolar to Erol-LP) ( Ix ) and in excess of Erol-Lp 
(0.0326 | i M ) (I .5x) into reactions containing 0.18 inM insulin, 1 m M DTT, 0.218 juM 
PDI and 0.022 | j M Erol-Lp (Fig. lOB). The addition of Erol-Lp to the PDI-catalysed 
reaction increased the appearance of insulin reduction in this case with the level of insulin 
reduction leaving baseline at -40 minutes compared with -60 minutes in the solely PDI-
catalysed reaction. However, the addition of FAD seeined to have no further effect on 
insulin reduction. Moreover, addition of FAD in excess (1.5x) seemed to mildly inhibit 
Results Chapter 1 74 
the reaction with reduction only leaving baseline after -50 minutes. Together these data 
indicate that the addition of the flavin FAD does not influence Erol-LP-mediated 
reduction of insulin via a PDI oxidation chain. 
The data obtained for the insulin assay varied between experiments with Erol-LP 
catalysing insulin reduction in only one experiment (Fig. 9A) and inhibiting insulin 
reduction in others (Fig. 9B and 10/4). Since these reactions were cairied out at room 
temperature, temperature fluctuations may be responsible for inconsistent data between 
rates in the experiments (Compare Fig. 9B with Fig. lOA and B). To investigate whether 
addition of Ero 1-LP catalyses PDI-dependent reduction of insulin we kept temperature 
constant by performing the assay at 37 "C (Fig. 11). Since the reaction would be much 
faster, ODsoo readings were taken every minute. This technique allowed a much closer 
monitoring of insulin reduction but only small differences were observed upon the 
addition of Erol-Lp. 
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T h e Init ial e f fec t of E r o l - L f i o n i n s u l i n r e d u c t i o n at 37 d e g r e e s C e l s i u s 
1.400 
c 1.000 
c 0.800 
<t 0 600 
a.40o 
Time (m) 
Figure 11. The addition of Ero1-Lp to the in vitro reduction system at 37 degrees Celsius. A, 
This insulin reduction assay was completed at 37 °C, taking ODeoo readings every minute. Insulin and DTT 
and PDl concentration are as optimised and Ero1-L(3 is added at 0.0318 |.iM. 
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3.1.2.5 Purified Ewl-Lftdoes not contain FAD 
Genetic approaches have confirmed that FAD is necessary for oxidative folding in the ER 
since depletion of riboflavin, a precursor of FAD, leads to defects in the oxidative folding 
of protein substrates (Tu el al, 2000). Furthermore, more recent work has indicated that 
oxidative folding is sensitive to levels of free FAD, directly affecting the viability of 
yeast with a the erol-1 mutation (Tu and Weissinan, 2002). 
For our studies, an Erol-LP expression construct was designed based on the truncated 
Erolp that was successfully expressed and crystallised by Gross and colleagues (Gross et 
a].. 2004). Truncated Erol-Lp was expressed in Origami bacteria and purified using Ni 
Aff ini ty chromatography. Erol-LP was insoluble and had to be refolded using urea (D. 
Brown. J. A. Gatehouse and A. M. Benham, unpublished data). The amount of Erol-LP 
obtained was very low, approximately 250 ng jal ' correspondmg to 0.375 \iM 
concentration. In order to visualise this, 0.3125 p.g was loaded on an SDS-PAGE gel with 
an equal amount of purified PDl and an equal volume of Erol-LP-myc transfected lysate 
(Fig. 12/1). Purified PDl resolved into a tight band approximately 60-65 kD, however the 
purified Erol-LP was only detected at low levels, resolving as a faint band at -50 kD 
(Fig. 12A, compare lane 2 with lane 1). Despite loading the same amount of protein, 
bands of equal intensity were not seen, suggesting that either the concentration of purified 
Erol-Lp was lower than anticipated or that the coomassie differentially stains the two 
proteins. A western blot was run to confirm the presence of purified Erol-LP (Fig. \2B). 
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F i g u r e 12 . Purification of Ero1-Lp. A, 0 .3125 p g pur i f ied Ero1-Lp and 0.3125 ng PDI we re ran on 
reducing (R) S D S - P A G E . T t i e resul t ing gel was c o o m a s s i e s ta ined in order to visual ise all prote in o n tt ie 
gel . S, T t ie s a m e reduced samples were loaded as in A , only tt i is t ime were immunob lo t ted for t l ie 
p resence of Ero1-Lp us ing the ant i -Erop ant ibody. T t i e immunob lo t t i ng conf i rms tt ie p resence of a faint 
Ero1-Lp b a n d in the coom iasse gel (compare S, lane 1 wi th A, lane 1). 
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In order to study E r o l - L P activity, it was important to establish whether or not the 
purified protein contained any FAD. We tested for the presence of FAD using 
spectrophotometry. Glucose oxidase was used as a positive control since each subunit of 
this homodimeric enzyme contains a co-enzyme molecule of FAD (Pazur and Kieppe, 
1964). The characteristic fluorescence for flavin is 525nm as has been shown during 
studies with other FAD-bound enzymes (de Vet and van den Bosch, 2000; Rand et al., 
2006). 
A range of glucose oxidase standards were analysed: one at equimolar concentration to 
the purified Erol-L(3 purified stock (0.375 |.iM), one at 1 ) l i M and one at the glucose 
oxidase stock concentration of 17.5 |.iM. An absorbance spectrum was taken in the range 
of 200-800 nm using all three standards (Fig. 13/1, B and C). A l l standards gave an 
absorbance peak reading at 525 nm indicating the presence of flavin. Purified Erol -Lp 
however failed to show a similar peak, indicating the lack of FAD in the purified extract 
(Fig. 13D). Bovine serum albumin was used as a control for the presence of protein in the 
sample. A solution of BSA was made up to 0.1 (Ag/ml and its absorbance in the low 
wavelengths (200-350 nm) examined (Fig. \?>E). A peak at -200 nm indicated the 
presence of BSA. Purified Erol-L(3 gave a peak at -270 nm indicating that protein was 
indeed present in the purified E r o l - L P sample. Taken together with the very pale colour 
of the purified Ero l -Lp protein solution, we concluded that the purified Erol-Lp does not 
contain FAD. 
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F i g u r e 13 . Purified Ero1-Lp does not contain FAD. A n a b s o r b t i o n s p e c t r u m of t h e F A D -
c o n t a i n i n g e n z y m e g l u c o s e ox idase (GOx) was under taken us ing concen t ra t ions In excess (17.5 (.iM) 
(A), equ imolar (0.375 pM) (S) a n d sl igt i t ly In excess (1 (.iM) (G) to tt iat of pur i f ied Ero1-Lp. T t ie 
abso rbance of the pur i f ied Ero-Lp w a s then taken but showed no s ign of a character is t ic flavin peak (D). 
A contro l for the p resence of prote in w a s under taken using bov ine s e r u m a lbumin In excess of the 
concent ra t ion of pur i f ied E ro1 -Lp (£ ) . Pro te in content of the pur i f ied Ero1-Lp w a s then ana lysed (F). 
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3.1.3 Discussion 
3.1.3.1 Homodimehsation of wild-type Erol-Lfi 
Here data is presented, showing that, taken together with the work of Dias-Giinasekara 
and colleagues (Dias-Gunasekara et «/., 2005), Erol-LP is able to form homodimers. The 
functional significance of Ero homodimers remains unknown. However, previous work 
has demonstrated that the Ero 1-La mutant C391A shows a lower affinity for PDI yet it is 
able to rescue the temperature sensitive yeast mutant erol-1 (Bertoli et a/., 2004; Cabibbo 
et al, 2000; Pagani et ciL, 2000). Thus, both hERO-PDI association and hERO 
dimerisation may be important in maintaining the oxidative folding pathway in the ER. 
Using co-immunoprecipitation techniques, we show that differentially tagged wild-type 
Erol-Lp associates in vivo (Fig. 3). During lysis, the alkylating agent N E M was used to 
trap any disulfide complexes by sequestering any thiols. Co-immunoprecipitated Erol-LP 
homodimerises as a mixture of covalent and non-covalent interactions. Homodimers were 
also resolved under non-reducing conditions in the presence of SDS (Fig. 3). 
Further work by our group led to the discovery that the C-X-X-C-X-X-C motif is 
important in dimerisation. By studying the mutant C396A, they were able to show that 
this residue is important for dimer establishment since the mutation did not give rise to 
dimers. The Erolp crystal data gathered by Gross and colleagues allowed a model for Ero 
dimerisation to be developed (Gross et al, 2004). 
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A 
F i g u r e 1 4 . A structural model of an Ero-Ero homodimer. A, Here two E r o l p m o n o m e r s form a 
h o m o d i m e r th rough non-covalent h y d r o g e n bond ing of two symmetr ica l F A D mo lecu les . The glycans are 
s h o w n on the exter ior of the d imer by bal l and st ick representat ion. 6 , A c loser v iew of the d imer interface 
s h o w s the locat ion of the E r o l p ac t i ve s i te cys te ines (Cys^^-Cys^^^) and the non-ac t i ve cys te ines ( C * - C ^ ' ' ) . 
FAD is s h o w n at the centre of the in ter face by the st ick and space fi l l ing represen ta t ion . Th is mode l is taken 
f rom (D ias -Gunasekara et al., 2 0 0 5 ) 
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This model illustrates the homodimerisation of two Erolp molecules held together by 
hydrogen bonds at the interface (Fig. \4A). The dimer interface consists of the two bound 
FAD molecules adjacent to the active site cysteines (Cys'^^-Cys''^^) (Fig. 145) which 
conesponds to Cys'''''-Cys'''^' in Erol -Lp. Given that the C396A mutant abolishes the 
formation of dimers, it is likely that by mutating this residue the loss of dimers occurs 
indirectly via the loss of the FAD cofactor. The proximity of non-active site cysteines 
(upstream of the C-X-X-C-X-X-C motif) to the dimer interface, may account for the 
observation of disulfide-dependent complexes suggested by this chapter. The formation 
of disulfide bonds between free cysteines in Erol-LP monomers could potentially 
strengthen the dimer. Mutations targeted towards these cysteines can now be used to test 
this hypothesis. 
3.1.3.2 Reduction in the ability of FAD-binding mutants to interact with PDI 
and the formation of FAD-binding mutant homodimers 
Observations that the C396A mutation disrupts the formation of dimers led to the 
hypothesis that mutations in the FAD-binding domain may also prevent dimerisation of 
Ero l -Lp . Initially, the ability of these mutants to bind PDI was investigated. Previous 
work has shown that alkylation with N E M is required in mammalian cells to detect 
hEROs disulfide bound to PDI (Benham et ciL, 2000; Mezghrani et al, 2001). Since the 
mutations did not directly affect any active-site cysteines, it was assumed that PDI 
binding would not be affected by mutations in the FAD-binding domain. However, the 
yeast conditional erol-1 mutant strain is unable to oxidise yeast PDI and substrate 
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proteins remain in a reduced state (Frand and Kaiser, 1999). We provide data here 
showing that FAD-binding mutants have impaired covalent interaction with PDI (Fig. 6C 
and D). However, non-covalent interactions seem largely unaffected by the mutations, 
since monomeric Erol-Lp is detected after co-immunoprecipitation with PDI and 
analysis under non-reducing conditions (Fig. 6D). Hence, Erol-Lp can interact with PDI 
in a disulfide and flavin-fold independent manner. Both G252 and H254 therefore are 
required by EroI-LP for covalent PDI association. This seems unusual considering these 
residues are not directly involved in PDI binding and the buried FAD cofactor is not 
likely to be adjacent to the Erol-LP-PDI docking site. However, recent work has 
highlighted that Erol-PDI specificity arises froin both active site cysteines (Kulp et al, 
2006). This work contradicted previous studies which suggested that Erolp cannot 
oxidise the A^-terminal active site of PDI (Tsai et al, 2002; Tu et a/., 2000)). Since the 
Erol proteins used in these studies was missing FAD, the presence of the cofactor may be 
essential for the complete recognition and hence interaction of the active site domains of 
PDI. 
Despite the fact that FAD-binding mutants were able to associate with PDI, Ero-Ero 
interactions did not depend on the FAD-binding site. The phenotypes caused by the erol-
1 and erol-2 mutants therefore can not be accredited to the failure of Erolp to form 
homodimers. 
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3.1.3.3 In vitro activity ofEwl-L/3 in the insulin reduction assay 
By using purified PDI and Erol-Lp we were able to construct an assay to study the 
activity of both proteins. An insulin reduction assay was designed and optimised based 
upon the one established by Luthman and colleagues in 1979 (Holmgren, 1979). PDI is 
able to oxidise DTT in vitro in a concentration-dependent manner (Fig. 8). In one 
experiment, the addition of catalytic concentrations of purified EroI-L(3 increased the rate 
of insulin reduction (Fig. 9A). However, in the majority of experiments, no increased rate 
of reduction was observed, suggesting that the purified protein is inactive. Addition of 
FAD to the reaction did not increase the rate of oxidation further suggesting the purified 
EroI-LP is inactive. 
Inactivity of the Erol-LP may be a consequence of the method by which it purified. 
Perhaps refolding of the protein during purification was not efficient and resulted in the 
formation of a non-native protein. Alternatively, inactivity may be a consequence of 
inefficient binding of FAD. Attempts can now be made to generate an active protein by 
optimising the refolding step of the purification method. Upon obtaining active, piuified 
Erol-L(3, work wil l concentrate on studying its functional activity in vitro. As well as 
studying the effect of introducing active EroI-L(3 to the insulin reduction assay, 
comparisons of functional activity can be made using other assays such as the RNase A 
assay. This assay has been successful in functional studies of redox isomerases (Fuchs et 
at., 1967; Goldberger et al, 1963; Lundstrom and Holmgren, 1990) and may help to 
further elucidate Erol -Lp and FAD function in disulfide bond formation. 
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3.2 Characterisation of an anti-Erol-L(3 polyclonal antibody 
3.2.1 Introduction 
Antibodies are serum immunoglobulins (Igs) that are able to bind specific antigens. The 
ability of antibodies to bind antigen with a high degree of affinity and specificity make 
them a valuable tool in molecular and cellular biology. Some common uses of antibodies 
include being employed in the identification and separation of proteins in Western blots 
and immunoprecipitations, differentiation of cell types using flow cytometry and 
examination of protein expression in tissues by immunohistochemical staining. 
When studying protein interactions, the identification of specific proteins is vital. Gel 
staining methods are common when using purified proteins, however, when total cell 
lysates are being analysed, this method is too unspecific. Custom polyclonal antibodies 
(pAb) and monoclonal antibodies (mAb) are available for protein analysis. In the case of 
pAbs, animals are given an injection of antigen or antigen/adjuvant mixtures to induce 
antibody production. This production is usually monitored by collecting blood from the 
animal during the course of immunisation. The serum wi l l contain multiple antibodies 
against the same antigen. In the case of mAbs, animals are given injections of antigen or 
antigen/adjuvant mixtures to induce specific B cells, which can be fused with 
immortalised cells to produce hybridomas. These immortalised lymphocytes are products 
of a single B cell clone and thus, produce a single set of antibodies against the antigen the 
animal was raised against. Making the choice whether to use mAbs or pAbs is usually 
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influenced by the desired application and time or financial constraints. Polyclonal 
antisera can be obtained from rabbits within 1-2 months; however this depends on the 
primary and secondary response. The establishment of a hybridoma and the production of 
monoclonal antibodies however, can take up to 6 months (Leenaars and Hendriksen, 
2005) . 
Since, mAbs target a specific, single antigenic epitope, any alteration in conformation by 
denaturation, reduction, post-translational modification or association with other proteins 
may influence binding affinity. The impact of conformational change on pAbs however is 
less likely to be a concern since pAbs recognise multiple epitopes. The use of pAbs for 
immunoprecipitation methods is advantageous since pAbs tends to recognise multiple 
epitopes better since polyclonal sera are a composite of antibodies with unique 
specificities. Another advantage of pAb use is their stability over a broad pH and salt 
concentration (Lipman et al., 2005). 
Our aim was to produce an Ero l -Lp polyclonal antibody for use in immunoprecipitation 
and immuno- or Western blotting. The antigen was a recombinant, truncated human 
Erol-Lp protein expressed in E. coli. The antibody was raised in New Zealand white 
rabbits by Sigma-Genosys. Although an anti-peptide Erol -Lp antibody has been 
previously made, it is unable to immunoprecipitate Ero l -Lp (Dias-Gunasekara et al., 
2006) . 
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Animals were bled periodically in order to analyse the progiession of the Ab response to 
immunisation. After the polyclonal sera were obtained from the animals, it was necessary 
to characterise the specificity and sensitivity to Erol-Lp. This chapter characterises 
polyclonal antibodies against recombinant Erol-Lp at various stages post-immunisation. 
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3.2.2 Results 
3.2.2.1 Polyclonal antiserum from rabbit B2 is able to recognise transfected 
but not endogenous Erol-Lp 
In total, three rabbits were immunised against Erol-Lp. When bleeds were received, they 
were left to clot overnight, and the serum was removed. This was centrifuged several 
times to remove any remaining blood cells and was subsequently treated with 0.01% 
sodium azide to prevent infection. Initially, antisera from each rabbit were tested for the 
ability to recognise transfected Erol-LP-myc in a Western blot. Erol-LP-myc was 
transfected into HeLa cells, cells were lysed and post-nuclear lysates were run on 
reducing SDS-PAGE. Proteins were then transferred to nitrocellulose and subsequently 
analysed by immunoblotting (Fig. I ) . Antisera from rabbit B2 2"'' and 3''' bleed (Fig.lA), 
rabbit B3 2"'' and 3"* bleed (Fig. IS) and rabbit B7 l " and 2"'' bleed (Fig. IC) were 
analysed. The ability of the antisera to detect endogenous Ero l -Lp was also tested by 
using a mouse pancreas tissue lysate which expresses Ero l -Lp . A non-transfected 
negative HeLa total cell lysate control was also used. As well as immunoblotting using 
the new antisera, lysates were also subjected to immunoblotting using the current anti-
peptide Erol -Lp antibody and the anti-PDI antibody as a control. In the case of the B2 
antisera tests, lysates were also subjected to immunoblotting with the anti-myc antibody 
in order to determine which band corresponded to Ero I-LP (Fig. \A). 
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F i g u r e 1 . B2 antiserum is able to recognise transfected Ero1-Lp-myc. E r o l - L p t rans fec ted 
cel ls (TF), m o u s e (Mm) panc reas and tHeLa total cell l ysa tes (tcl) were genera ted . Ant isera f r o m rabbit 
B2 2 " " b leed (B2.2S) and 3'" b leed (B2.3S) {A), B3 2 " " b l eed (B3.2S) a n d 3"^ b leed (B3.3S) (6) a n d B7 1^' 
b leed (B7.1S) a n d 2™* b leed (B7.2S) (C) were ana lysed for recogni t ion of E r o l - L p in Wes te rn blot t ing 
(WB) at 1:200. As cont ro ls , lysates were also immunob lo t ted f o r a n t i - E r o 1 - L p (a-Erop) , ant i -PDI a n d ant i -
myc {A only). 
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Immunoblotting using the B2 2'"^ ' bleed antiserum showed no detection of transfected or 
endogenous Erol-LP (Fig. lA, lanes 1 and 2). However, analysis of the 3"' bleed showed 
recognition of the Erol-LP-myc transfected protein (Fig. \A. lane 4). Immunoblotting 
with the anti-myc antibody (Fig. lA, lanes 13-15) did not detect expression of Erol-LP in 
the pancreas but Erol-LP was detected in the transfected lysate as expected. The B2 3"* 
bleed, however, was unable to recognise endogenous Erol-Lp (Fig. lA, lane 5). The 
current anti-Erol-Lp anti-peptide antibody, however, was able to recognise both 
endogenous and transfected Erol-Lp (Fig. \A, lanes 7 and 8). 
Analysis of rabbit B3 2"^ * bleed revealed a weak recognition of transfected Erol-LP and 
endogenous Erol-Lp (Fig. IS, lanes 1 and 2). After further immunisation, recognition of 
endogenous Erol-Lp and transfected Erol-LP remained weak. (Fig. \B). The image 
produced from B3 3''' bleed analysis is rather overexposed, meaning that it is likely that 
only low levels of endogenous Erol-Lp were detected. Regardless, rabbit B3 was more 
successful at recognizing endogenous Erol-LP than rabbit B2. 
Analysis of rabbit B7s T' and 2'"^  bleed showed no recognition of endogenous or 
transfected Erol-LP (Fig. IC, lanes 1 and 2). Taken together, these data show that after 2 
boosts, antiserum f rom rabbit B7 was unable to recognise endogenous or transfected 
Erol-LP, B3 was not able to recognise transfected Erol-LP but was able to weakly 
recognise endogenous Erol-LP from mouse pancreas and rabbit B2 antisera was able to 
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recognise transfected Erol-LP-myc. showing a moderate to strong signal. Despite this, 
B2 failed to recognise endogenous Erol-LP from mouse pancreas. 
In order to confirm that the band seen in figure \A lane 4 was the transfected Erol-LP-
myc, the antiserum from the 3'^ '' bleed of rabbit B2 was analysed after transfected lysates 
had been subject to immunoprecipitation with the anti-myc antibody (Fig. 2A). Pre-
immune serum from the B2 rabbit was used as a negative control in this instance and the 
current anti-peptide Erol-LP antibody was used as a positive control. Lysates were 
generated by transfection of cDNA from two Erol-LP-myc maxipreps into HeLa cells. 
Mouse pancreas provided an Erol-LP-positive lysate while untransfected HeLa lysate 
provided a negative control. Lysates were subjected to immunoprecipitation with the anti-
myc antibody for 2 h at 4 °C. The protein A sepharose beads were then washed twice 
with lysis buffer before proteins were liberated. Any immunoprecipitating or co-
immunoprecipitating proteins were then loaded onto SDS-PAGE gel and subsequently 
immunoblotted. 
After IP, the current anti-EroI-LP antibody recognised both old and new transfected 
Erol-Lp (Fig. 2, compare lane 12 with lane 9). This antibody also recognised a non-
specific band from mouse pancreas lysate (Fig. 2, lane 10). Conversely, pre-immune 
serum from the B2 rabbit was unable to recognise either transfected or endogenous Ero l -
Lb (Fig. 2, lanes 1-2 and 4). Antiserum from the 3'^ '' bleed was able to recognise Erol-LP-
myc translated from both old and new constructs (Fig. 2, lanes 5 and 8). 
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F i g u r e 2 . B2 antiserum recognises transfected Ero1-L| i-myc after immunoprecipitation. 
A, t rans fec ted (TF) , t issue ( M m panc reas ) and H e L a total cell lysates (tcl) w e r e genera ted . Lysates were 
sub jec ted to immunoprec ip i ta t ion (IP) us ing the ant i -myc ant ibody to isolate t rans fec ted myc- tagged 
pro te ins . Iso lated proteins were de tec ted using W e s t e r n blott ing (WB) us ing B2 p re - immune se rum (P-
IS) ( lanes 1-4), 3 '" b leed an t i se rum (B2.3S) ( lanes 5-8) (both at 1:200) a n d the current polyclonal 
an t ibody aga inst Ero1-Lp (a-EroP) ( lanes 9-12) . 
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Contrastingly, this polyclonal serum was unable to recognise endogenous Erol-L(3 (Fig. 
2, lane 6). This is consistent with data obtained previously (Fig lA, lane 4). 
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3.2.2.2 Polyclonal antiserum from rabbit B2 is able to immimoprecipitate 
transfected Ero]-Lj8 
Our next aim was to ascertain whether or not the polyclonal antiserum from the 3"* bleed 
of rabbit B2 was able to isolate Erol-LP by immunoprecipitation. This would provide us 
with a useful tool since the cunent anti-Erol-LP antibody wi l l not recognise Ero l -Lp in 
immunoprecipitations. Transfected, tissue and non-transfected lysates were generated as 
previously and were subjected to immunoprecipitation using the B2 pre-immune serum, 
the 3'^ '' bleed serum and the anti-myc antibody. Lysates were incubated with protein A 
sepharose beads for 2 h at 4 °C before being washed. Proteins were then liberated and 
separated by SDS-PAGE. Proteins were transfened and subsequently immunoblotted 
with the anti-myc antibody in order to detect any immunoprecipitating myc-tagged E r o l -
LP (Fig. 3). 
Immunoblotting with the anti-myc antibody showed that the anti-myc control IP had been 
successful since EroI-LP-myc could be detected (Fig. 3, lane 7). Analysis of the anti-myc 
immunoblot of lysates subjected to IP with the B2 pre-immune serum showed that no 
immunoprecipitation of myc-tagged Erol-Lp had taken place (Fig. 3, lane 1), thus, the 
pre-immune serum was unable to recognise EroI-LP-myc in IP. This is consistent with 
previous work since 82 pre-immune serum was unable to recognise Erol-Lp-myc in 
Western blots (Fig. 2, lanes 1 and 4). 
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F i g u r e 3. B2 antiserum is able to immunoprecipitate transfected Erol-Lp. Ero1-Lp-myc 
t ransfected (TF), m o u s e (Mm) panc reas a n d HeLa total cell lysates (tcl) w e r e genera ted for analys is . 
Lysates were sub jec ted to immunoprec ip i ta t ion (IP) using 8 2 p re - immune s e r u m (P-IS) ( lanes 1-3), 3 '" 
b leed ant iserum (B2.3S) ( lanes 4-6) a n d the ant i-myc ant ibody ( lanes 7-9). Af ter prote ins were l iberated 
f rom protein A sep t ia rose beads thiey were separa ted by 8 % S D S - P A G E and subsequent l y 
immunob lo t ted us ing t t ie ant i -myc ant ibody. 
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After immiinoprecipitation with the B2 3"' bleed serum, immunoblotting with the anti-
niyc antibody revealed the presence of Erol-LP-myc (Fig. 3, lane 4) indicating that the 
3"' bleed polyclonal antiserum was able to recognise Erol-Lp-myc in 
immunoprecipitation. A l l mouse pancreas lysates and non-transfected HeLa total cell 
lysate controls were negative as expected. 
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3.2.2.3 Antisera from rabbit B2 do not cross-react with Erol-La 
We also tested the ability of the termmal bleed to recognise transfected Ero l -La as well 
as Ero l -Lp . Since Ero l -La and Ero l -Lp share structural characteristics, it was 
imperative that an investigation was carried out to see i f the antisera would cross-react 
with Ero l -La . Since immunoblotting with the original anti-peptide Erol -Lp antibody 
was improved using 0.1% SDS (S. Dias-Gunasekara, and A. M . Benham, unpublished 
data), SDS was used in the incubation of some primary immunoblots to detemiine 
whether this would improve the B2 signal. 
Both Erol-La-myc and Erol-LP-myc lysates were generated by transfection into HeLa 
cells. An untransfected HeLa cell lysate was used as a control. After separation of 
proteins by SDS-PAGE and subsequent transfer to nitrocellulose, membranes were 
immunoblotted using the anti-myc, anti-Erol-Lp, anti-PDl antibodies and the 3'^ '' and 
terminal bleeds of the B2 rabbit (Fig. 4). The use of SDS in the primary immunoblot of 
anti-Erol-LP and both B2 antisera cleaned up the background (Fig. 4, lanes 4-6 and 10-
15). Both the 3"^  and terminal bleed antisera recognised the Erol-LP-myc transfected 
protein without cross-reacting with the Erol-La-myc transfected protein (Fig. 4 compare 
lane 11 with lane 10 and lane 14 with lane 13). The terminal bleed antiserum however did 
not show improved recognition of Ero l -Lp over the 3"* bleed antiserum (Fig. 4 compare 
lane 14 with lane 11). Taken together, these results show that although there is no 
increased recognition of Erol-LP from the temiinal bleed antiserum, antisera from the B2 
rabbit does not cross-react with Erol-La-myc. 
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3.2.3 Discussion 
Here, we characterised a polyclonal antibody raised against the tissue-specific ER 
oxidoreductase Erol -Lp. The intended use for this antibody was to recognise Ero l -Lp or 
complexes of Ero l -Lp in both immunoblots and immunoprecipitations. 
Initially, three rabbits were immunised but upon inspection of their bleeds, one antiserum 
performed better - from rabbit B2 - when tested for immunoblotting on Erol-LP-myc 
transfected lysates (Fig. I). However, the antiserum was unable to recognise endogenous 
EroI-LP from mouse pancreas. Polyclonal antisera consist of many antibodies raised 
against the same antigen. This 3"* bleed antiserum should in theory be able to recognise 
endogenous mouse pancreas Erol -Lp. One possible explanation is that the epitope(s) the 
antiserum was raised against is not contained in murine Erol-Lp, perhaps because the 
recombinant Erol-LP used as antigen was not properly folded. The B2 antiserum was 
also able to recognise Erol-LP in immunoprecipitation reactions, something the cuirent 
anti-peptide anti-Erol-LP antibody was unable to do (Fig. 2). 
Checking for cross-reactivity of antisera is an important step. This is especially crucial 
when studying a protein like Erol-Lp that may share epitopes with other proteins such as 
Ero l -La . Thus, we showed that the 3'^ '' bleed antiserum was unable to recognise E r o l - L a 
in immunoblots whilst recognising Ero l -Lp (Fig. 4). Acquisition of the terminal bleed 
from rabbit B2 allowed us to investigate whether or not recognition of Erol-LP had 
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improved. Upon inspection, this was not the case. However, the addition of a small 
amount of the detergent SDS provided a cleaner Ero l -Lp signal (Fig. 4). 
Although B2 does not recognise Erol-LP in pancreas, it may be worth testing other 
secretory tissues such as stomach and testis to determine whether all native Ero l -Lp 
proteins fail to be recognised by this serum. It wi l l also be interesting to test the new 
antiserum using immunohistochemistry to confirm these findings. The B2 serum could 
also prove useful in defining Erol-Lp complexes by IP in transfected cell lines. 
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3.3 Towards the characterisation of the interactions between the 
PDI homolog, PDlp and Erol-La and Erol-Lp 
3.3.1 Introduction 
Numerous eukaryotic PDI homologs have been discovered with an extensive range of 
both domain organisation and active-site chemistries (Ferrari and Soling, 1999; Freedman 
et ciL. 2002). A handful of human PDI homologs exhibit tissue-specific distribution. 
PDIp, endoPDI and PDILT are homologs of PDI restricted to the pancreas, endothelia 
and testis respectively (Desilva et al, 1997; Sullivan el a/., 2003; van Lith et al., 2005). 
The existence of tissue-specific PDI homologs may be due to the requirement for the 
folding of tissue-specific proteins. However, the identity of such tissue specific substrates 
is currently unknown. 
PDIp was characterised in 1997 (Desilva et al., 1997). PDIp shares the same a b b' a ' 
domain organisation as PDI (but lacks the acidic C-terminal region), with around 45% 
identity and around 66% similarity to PDI (Volkmer et ol, 1997). Shortly after its 
identification, PDIp was shown to bind both peptides and misfolded proteins, something 
that has not been substantiated in other PDI homologs (Klappa et ai, 1998b). Interaction 
with native proteins however, was not detected, suggesting that, like PDI, PDIp is able to 
act as a molecular chaperone. This was further conoborated by the fact that some of the 
misfolded proteins PDIp was able to bind did not contain any Cys residues, suggesting 
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that in these cases, binding of PDIp to substrate proteins does not require any oxidase or 
isomerase activity. An experiment in the same study, however, did reveal that PDIp was 
able to reduce disulfide bonds in insulin, suggesting that, like PDI, PDIp is redox active 
(Klappat-ra/.. 1998b). 
More recently, peptides with tyrosine and tryptophan residues have be identified as 
recognition motifs for PDIp binding (Ruddock et al, 2000). Studies with non-peptide 
ligands have revealed that hydroxyaryl groups are the structural motifs for the binding of 
PDIp (Klappa et «/., 2001). These key investigations were carried out using chemical 
cross-linkers and radio-labelled peptides to isolate substrate-enzyme interactions. 
The b' domain of PDI is essential but not sufficient for peptide binding (Klappa et al, 
1998a). The b' domain of PDIp shares around 39% identity with that of PDI. Further to 
this, translocation of presecretory proteins into dog pancreatic microsomes with 
subsequent cross-linking, shows that PDIp and PDI can interact with the same substrates 
(Klappa et al., 1995). More recent studies using domain fragments have substantiated that 
the peptide-binding properties of PDIp and PDI are similar (Klappa et al, 2001). Thus, it 
remains likely that members of the PDI family exhibit an overlap in substrate specificity 
despite the apparent elucidation of specific PDIp recognition motifs. 
This is somewhat surprising when considering the tissue distribution of PDI and PDIp. 
Northern-blot analysis has revealed that PDIp niRNA is restricted to the pancreas 
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(Desilva ei ai, 1996) and furthermore, this has been confirmed at the protein level (Dias-
Gunasekara et al., 2005; Klappa et al., 1998b). Specifically, PDIp is expressed in the 
pancreatic exocrine system, in the acinar cells (Desilva et al., 1997; Dias-Gunasekara et 
al, 2005). Recent work has revealed that PDI is also expressed in the acinar cells, 
alongside PDIp (Dias-Gunasekara et al, 2005). The co-existence of PDI homologs in the 
same intracellular compartment in the same cell type is not exclusive to PDIp or PDI. 
However, it is conceivable that both PDI and PDIp are redox-active but do somehow 
differ in their substrate specificity. Pancreatic zymogens were proposed as possible PDIp-
specific misfolded substrates although, studies have shown that sequences exposed in 
unfolded fonns of pancreatic zymogens can bind PDI as well as PDIp (KJappa et al., 
1998b). 
The PDI homolog ERp57 is able to act specifically on glycoprotein substrates through 
interaction with the ER chaperones calnexin and calreticulin via its b' domain (Oliver et 
al., 1999; Russell et al., 2004). It is possible that PDIp might exhibit substrate-specificity 
in a similar manner, especially since both PDIp and ERp57 share roughly the same b' 
domain sequence identity with PDI (Russell et al., 2004). Conversely, PDIp substrate-
specificity might simply be the consequence of a small difference in protein sequence of 
the b' domain and/or in other domains of PDIp, resulting in the binding of a set of 
peptides inaccessible to PDI. Another theory proposed by Ruddock and colleagues is that 
co-expressed members of the PDI family do not act on distinct proteins but rather 
cooperate by interacting with different parts of the polypeptide (Ruddock et al., 2000). As 
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of yet this has not been investigated. This could be confirmed by studying the ability of 
PDIp and PDI to substitute for each other in a reconstituted system. 
Despite the identification of numerous new human PDI family members in recent years, 
the role of these proteins in the mechanics of the oxidative protein folding system 
remains relatively unstudied. The identification and characterisation of the testis-specific 
PDI homolog PDILT showed that it associated with the human Ero protein Erol-La (van 
Lith et al., 2005). This was unusual since PDILT exhibits a non-classical S-X-X-C motif 
and is unlikely to be redox-active as an oxidase. 
The mechanism of oxidative protein folding in human pancreatic cells is of interest, given 
that protein misfolding and UPR have been shown to contribute to type I I diabetes 
(Nakatani et al., 2005; Ozcan et al., 2004). In order to ful ly understand the redox activity 
of PDI family members, it is of importance to not only characterise the interactions with 
substrates, but also with the potential source of oxidising equivalents, the Eros. PDI 
remains the only conventional human member of the PDI family that readily forms 
trapped disulfides with Eros. Does PDIp bind Ero l -La or Ero 1-LP? Ero 1-LP is expressed 
in acinar cells (Dias-Gunasekara et al., 2005), however the expression pattern of Ero l -La 
in pancreas is not known. 
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This chapter takes the first steps towards characterising the interactions of the pancreas-
specific oxidoreductase PDIp with the human Eros, E ro l -La and Erol-L(3, comparing 
their interactions with the classical redox enzyme PDI. 
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3.3.2 Results 
3.3.2.1 The cell lines AR42J and Panel do not express detectable levels of 
endogenous PDIp 
The rationale for investigating the interactions of the human Eros with PDIp came from 
the observation that endogenous PDIp from mouse pancreas cells was able to interact 
with the human Ero, Erol-LP (S. Dias-Gunasekara and A. M . Benham, unpublished 
data). Mouse pancreas tissue lysate was subjected to immunoprecipitation with the anti-
PDIp antibody and then immunoblotted for Erol-LP revealing an interaction. 
We endeavoured to use pancreatic cell lines to further study the interaction of PDIp with 
the human Eros. Mammalian cell lines express Eros at very low levels (Dias-Gunasekara 
et al, 2005). We therefore expected to have to transfect both E r o l - L a and Ero I-LP into 
mammalian pancreatic cell lines in order to observe their interactions with other disulfide 
isomerases. 
Initially, we tested the rat pancreatic cell line AR42J and the human pancreas epithelial 
cell line Panel for endogenous expression of PDIp. The mouse pancreas tissue lysate was 
used as a positive control and the human cervical carcinoma cell line HeLa was used as a 
negative control. Both cell lines and tissue were lysed in M N T lysis buffer, reduced and 
separated on a denaturing SDS-PAGE gel. Prior to this lysates were either incubated 
without (Fig. \A) or with (Fig. 15) ConA sepharose beads to isolate glycosylated, ER 
Results Chapter 3 107 
resident proteins. Proteins were then transferred and subsequently immunoblotted using 
the polyclonal antibody anti-PDIp. The tissue lysate gave a strong PDIp signal (Fig. lA, 
lane 1), consistent with the work of S. Dias-Guna.sekara (data not shown). This signal 
was cleaned up and somewhat diminished by ConA sepharose isolation to pull down the 
glycosylated proteins in the lysate (Fig. IS, lane 1). As expected, the lysate of the human 
cervical carcinoma cell line HeLa did not give a signal for PDIp (Fig. lA, lane 4 and B, 
lane 4). Similarly, the human pancreatic cell line Panel showed no expression of PDIp 
(Fig. lA, lane 3 and B, lane 3). Contrastingly, the rat pancreatic cell line AR42J showed 
expression of PDIp before ConA isolation (Fig. lA, lane 2) and after ConA isolation (Fig. 
IB, lane 2). The difference in expression level between the cell line AR42J and the 
mouse pancreas tissue lysate is most likely due to the volume/number of cells lysed. As a 
control, the same lysates were immunoblotted for the constitutively expressed PDI using 
the anti-PDI antibody (Fig. IC). This confirmed that all samples had protein in. 
Since the PDIp signal in the tissue lysate was so big, even after ConA sepharose clean up, 
the signal seen in the AR42J sample could possibly be from transfer of protein during 
loading or spill over from the lanes. In order to resolve this, ConA treated samples were 
rerun on an SDS-PAGE gel with a lane left in between the tissue lysate and the AR42J 
cell lysate (Fig. I D ) . The AR42J sample showed expression of PDIp, suggesting that the 
original loaded sample was not the result of protein transfer from one lane to another. 
However this band ran at a lower molecular weight than that seen in figure lA . The HeLa 
lysates also gave a signal in this region, despite not showing any signal in the previous 
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experiment. These data were not conclusive in distinguishing whether or not there was 
endogenous PDIp expression in the AR42J cell line. 
We decided to further investigate which cell lines endogenously expressed the PDIp 
protein. We were careful this time to control loading by making sure the tissue lysate was 
the last sample to go on the gel. Again, lysates were immunoblotted for PDIp before and 
after being subjected to ConA sepharose treatment (Fig. IE). PDIp expression was 
detected in the tissue lysate but not in either the HeLa or AR42J cell lysates (Fig. IE, 
compare lanes 2 and 3 with lane 1). In order to confirm the presence of proteins in these 
samples, the same lysates were immunoblotted for PDI (Fig. IF). 
Interestingly, the size of the bands resulting form this anti-PDI immunoblot were slightly 
different between AR42J and HeLa suggesting that human and rat PDI have slightly 
different molecular weights. This was consistent with the data obtained in figure IC. 
Together these data provide evidence that PDIp is not endogenously expressed in the 
pancreatic cell lines AR42J and Panel, despite being abundant in mouse pancreas tissue 
lysates. The initial detection of PDIp in these cell line lysates (Fig. lA and C) was most 
likely a consequence of protein carry-over or due to a degiee of cross-reactivity of the 
anti-PDIp antibody with rat and human PDI. 
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Figure 1 . The pancreatic cell lines AR42J and Panel do not express PDIp. A, Post-nuclear total 
cell lysates (tcl) (lanes 2-4) or tissue lysates (lane 1) were run on a reducing (R) SDS-PAGE gel in order to 
resolve proteins. Proteins were ttien transferred to nitrocellulose and immunoblotted for PDIp. B, The same 
lysates from A, were subjected to ConA sephiarose isolation at 4 °C for 2 li to separate out glycosylated 
proteins. Beads were spun down and washed before proteins were liberated. Proteins were thien separated on 
gel and immunoblotted for PDIp. C, As in A, lysates were resolved on a reducing gel but immunoblotted for 
PDI. D, E and F, proteins were separated by SDS-PAGE as in A, B and C but a lane was left blank in 
between tfie tissue lysate (lane 1) and the cell line lysates (lanes 2 and 3). 
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3.3.2.2 Establishing in vitro translation methods to study PDIp/Ero 
interactions 
Since endogenous expression of PDIp was not detected in the pancreatic cell lines we 
had, we explored in vitro translation methods in order to study the interactions of PDIp 
with the human Eros. We utilised the constructs available to us (Table 1). In order to 
translate proteins from the constructs available, plasmids were linearised using unique 
restriction sites. An example of pBS.PDIp linearisation with Xbal can be seen in figure 2. 
Table 1 - Plasmid constructs for transcription and subsequent translation 
Construct Tag Plasmid Restriction Enzyme 
Ero1-La 
Ero1-Lp 
PDIp 
PDILT 
PDI 
Myc (x 3) 
Myc (X 3) 
Myc (x 3) 
pcDNA3.1 
pcDNA3.1 
pBluescript II SK 
pcDNA 3.1 
pBluescript II SK 
EagI 
EagI 
Xbal 
Mlul 
Xbal 
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Once subjected to restriction digest, linearised DNA was transcribed to obtain mRNA for 
use in in vitro translation experiments. Initially, we tested the RNAs individually to 
verify that they were translated. PDILT (control), PDIp, Ero l -La , Erol-Lp. and PDI 
mRNAs were translated using the rabbit reticulocyte lysate system from Promega (Fig. 
3/\, S, C and D respectively). As a negative control, the lysate mixture was loaded 
without any RNA so any antibody signal could be verified as the protein of interest and 
not due to cross-reactivity with lysate components. 
As a positive control, transfected lysates were loaded. In figure 3, transfected proteins are 
labelled with a single asterix whilst translated proteins are labelled with a double asterix. 
PDILT-myc translated successfully (Fig. 3A, lane 1 (**)) but is smaller than the 
transfected protein (Fig. 3A, lane 2 (*)) due to the acquisition of A'-linked glycans /;/ vivo. 
Translation of PDIp was also successful (Fig. 36, lane 1 (**)). In this case, the tissue 
lysate positive was also glycosylated and thus migrates higher up in the gel (Fig. 3B, lane 
2 (*)). Some non-specific bands could be detected in the absence of RNA (Fig. 3A and B, 
lane 3). The translation reaction of Ero-La RNA produced low levels of protein (Fig. 3C 
lane 1 (**)) compared to the translation of Erol -Lp (Fig. 3C, lane 3 (**)). The positive 
Erol-LP-myc migrates higher in the gel due to it being a glycoprotein (Fig. 3C, lane 4 
(*)). PDI RNA was also translated successfully (Fig. 3D, lane 1 (**)) albeit at a lower 
level than PDILT (Fig. 3D, lane 2 (*)). 
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Since the transcripts were able to translate individually, we initially attempted to co-
translate PDIp with both Ero l -La and Erol-L(3 (Fig. 4). Proteins were co-translated 
together and individually as controls. Again, a negative control without RNA was used in 
order to detect any cross-reactivity with reticulocyte lysate components. PDlp translated 
in the presence of E ro l -La and Erol-Lp RNA as well as in the absence of other RNA 
and migrated as a -45 kD protein (Fig. 4A, lanes 1-3). This was unexpected since PDIp 
previously migrated at -60-65 kD in the absence of its glycans (Fig. 3B, lane 1). The 
tissue lysate PDIp positive was not detected by the anti-PDIp antibody (Fig. 4A, lane 4). 
The most likely explanation for this result is protein degradation of PDIp. 
In order to detect any interaction between PDIp and Eros, the two proteins were co-
immunoprecipitated from the co-translation reaction. The co-translation reaction mixture 
was made up to 100 f.tl for immunoprecipitation (IP). This mixture was subjected to IP 
using the anti-PDIp antibody. Immunoprecipitating and co-immunoprecipitating proteins 
were then isolated and separated by SDS-PAGE (Fig. 4B). 
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Figure 2. Linearisation and extraction of the pBluescript.PDIp construct. The 
pBluescript.PDIp construct (pBS.PDIp) was subjected to restriction digestion using the Xbal enzyme In 
order to linearise the plasmid for transcription (lane 2). After linearisation, the DNA was extracted from the 
reaction mixture using phenol/chloroform (P/C) techniques (lane 3). DNA was analysed on a 1% agarose 
gel. 
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Figure 3. Individual in vitro translation of disulfide oxidoreductase proteins. Proteins were 
translated using the rabbit reticulocyte lysate method. RNA from PDILT (A, lane 1), PDIp (B, lane 1), 
Erol-La (C, lane 1), Ero1-Lp, (C, lane 3) and PDI (D, lane 1) was translated. Cell transfectlons (TF) or 
tissue lysates (TL) were run and used as positive controls (*). The reticulocyte lysate minus any RNA was 
run as a negative control. Translation products are denoted as **. All resolved proteins were transferred 
onto nitrocellulose membranes and subjected to immunoblotting using the anti-myc antibody (A and C) for 
myc-tagged proteins or the anti-PDIp (6) or anti-PDI (D) antibodies. 
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Figure 4. Co-translation of PDIp with Eros in vitro. Proteins were translated individually or co-
translated using the rabbit reticulocyte lysate method. A, PDIp was translated individually (lane 3) or co-
translated with either Ero1-La (lane 1) or Ero1-Lp (lane 2). Ivlouse pancreas tissue lysate was used as a 
positive control for PDIp expression (lane 4). Control translations without RNA were also carried out (lane 
5). Mennbranes were subsequently immunoblotted with the anti-PDIp antibody. B, PDIp and Eros were 
either co-translated (lanes 1 and 2), or individually translated (lane 3-5). Positive transfected lysates were 
used as Ero controls (lanes 6 and 7) and a control without RNA was also used (lane 8). Translated 
proteins were immunoprecipitated with the anti-PDIp antibody. Proteins were then subjected to western 
blot for myc-tagged proteins using the anti-myc antbody. C, PDIp and Eros were either co-translated 
(lanes 2 and 3) or individually translated (lanes 4-6). A mouse pancreas lysate was used as a positive 
control (lane 1) and a negative control lacking RNA was loaded (lane 7) . Proteins were 
immunoprecipitated using the anti-myc antibody and subjected to immunoblotting using the anti-PDIp 
antibody. 
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Membranes were then immunoblotted with the anti-myc antibody in order to detect co-
immunoprecipitating myc-tagged Ero proteins. Positive myc-tagged Ero transfected 
lysates were run as controls (Fig. 4B, lanes 6 and 7). Erol-L(3 appeared to co-
immunoprecipitate with PDIp (Fig. 45, lane 2) however, Erol-Lp was also detected in 
the individually translated Erol-Lp sample (Fig. 45, lane 5). Individually translated 
Ero 1-LP should not have been detected by the anti-myc immunoblot after PDIp IP since 
PDIp was not present. Thus, the detection of EroI-LP in the co-translation and the 
individual translation were most likely due to non-specific binding of reticulocyte lysate 
to the beads and inefficient washing of the Protein A sepharose beads after IP. 
Co-immunoprecipitation was attempted the other way around, by immunoprecipitation 
using the anti-myc antibody and immunoblotting with the anti-PDIp antibody (Fig. 4C). 
No PDIp was detected in the individual and co-translations (Fig. AC, lanes 2-6) or in the 
tissue lysate control from the mouse pancreas which was not subjected to anti-myc IP 
(Fig. 4C, lane 1). In this case the tissue lysate was the same as that in figure 4A and thus a 
lack of signal may be attributed to protein degradation. Alternatively, PDIp may not have 
been detected in this immunoblot as a consequence of a failed anti-myc IP. To test this, 
reprobing with the anti-myc antibody verified that antibodies were present (data not 
shown). 
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Figure 5. Co-translation of PDI with Eros shows no interaction in vitro. As in figure 4, proteins 
were translated individually or co-translated using the rabbit reticulocyte lysate method. A, PDI (lane 3), E ro l -
La (lane 4) and Ero1-Lp (lane 5) were translated individually or PDI was co-translated with either Ero1-La 
(lane 1) or Ero1-L[5 (lane 2). Transfected lysates (TF) were used as a positive control for Ero1-L« or Ero1-L(5 
expression (lane 7 and 8). The translation reactions were subjected to anti-PDI immunoprecipitation and 
subsequently immunoblotted with the anti-myc antibody. B, The same membrane used in A, was blotted back 
using the anti-PDI antibody to confirm that the immunoprecipitation had isolated PDI. 
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The interactions of the human Eros with PDI have been documented (Benham el al., 
2000; Dias-Gunasekara et al., 2005). We attempted to use this in vitro translation system 
to verify that both Ero l -La and Erol-L(3 are able to interact with PDI. The human myc-
tagged Eros were individually translated or co-translated with PDI (Fig. 5). As previously 
described, the volume of the reaction was increased to 100 f.d for immunoprecipitation 
with the anti-PDI antibody. Proteins were liberated from the beads and immunoblotted 
for the myc-tagged Eros using the anti-myc antibody (Fig. 5A). Both the positive 
transfected Eros were detected strongly (Fig. 5A, lanes 7 and 8). However, no myc-
tagged Eros were detectable in any of the translation reactions (Fig. 5A, lanes 1-5). In 
order to verify that the anti-PDI immunoprecipitation was successful, IP samples were 
rerun and immunoblotted for PDI (Fig. 5B). Blotting back with PDI revealed that the 
immunoprecipitation had worked since PDI could be weakly detected in those samples in 
which it had either been individually translated or co-translated at a similar position to the 
positive controls (Fig. 5S, compare lanes 1-3 with lanes 7 and 8). Antibody heavy chains 
ran at 50 kD, showing that antibody had bound to the Protein A sepharose beads. 
Taken together these data did not show any interaction between the human Eros and 
PDIp or indeed PDI. A failure to detect interactions with PDI using in vitro translations is 
contrary to published data, and thus may be a consequence of low translation efficiency. 
The IPs did not co-immunoprecipitate any complexed proteins. This could be due to the 
fact that only small amounts of protein were recovered in the anti-PDI and anti-myc IPs 
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(Fig. 55, lanes 1-3 and data not shown) or that PDIp may indeed not interact with either 
Ero protein in vitro. 
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3.3.2.3 Cloning of PDIp for human cell line transfection 
Liposome-mediated transfection of plasmid constructs containing a gene of interest is a 
popular and successful method of studying protein interactions. This technique has been 
employed both in this project and published data (Dias-Gunasekara et al., 2006; van Lith 
et al., 2005). We have previously transfected both myc-tagged Ero 1-La and Ero L L P into 
human HeLa cells (Chapter 3.1). Since there is no endogenous expression of PDIp in 
HeLa cells, we would have to transfect in a plasmid containing the PDIp gene. 
Unfortunately, the construct we kindly received from M . Lan was in the pBluescript I I 
vector. Since pBluescript I I does not have a human cytomegalovirus (hCMV) promoter, 
the gene wi l l not transcribe in vivo. 
The human Ero pcDNA 3.1 constructs contain the vital hCMV promoter required for 
human cell expression. In order to express PDIp in HeLa cells, the PDIp construct would 
have to be removed from the pBluescript I I vector and ligated into the pcDNA 3.1 vector. 
EcoRI and Xbal were identified on pBS-PDIp and the empty pcDNA 3.1 plasmid as 
compatible restriction sites (Appendix 1). These enzymes are able to digest the multiple 
cloning site of the empty vector and either side of the PDIp insert of the pBluescript I I 
vector. Therefore, 5 |.ig of both D N A constructs were subjected to double-digestion with 
the EcoRI and X/^a/restriction enzymes. 
In order to isolate the liberated PDIp insert from the pBluescript I I vector, the products of 
both double-digestions were run on an agarose gel (Fig. 6A). The PDIp insert and the 
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linearised pcDNA 3.1 vector were cut out of the gel and subsequently isolated by gel 
extraction methods. The amount of the insert and vector were verified by running the 
extracted products on an agarose gel together with DNA standards of known 
concentration (Fig. 65). An approximation of both insert and vector concentration was 
determined by analysing pixel definition in the samples and comparing them with the 
DNA standards using the program T I N A 2.0 (Table 2). 
Table 2 - Vector and insert DNA concentrat ions 
Pixel Density Amount of DNA 
Ratio (in x 10 ng pixel"') 
Value (ng) 
Band 
100 ng Standard 97931 
200 ng Standard 159008 
500 ng Standard 349470 
Average 
Purified Insert DNA 164590 
Purified Vector DNA 160262 
1.02 
1.26 
1.43 
1.24 
121 
197 
433 
204 
199 
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Figure 6. EcoRi/Xbal digestion, purification and concentration determination of the PDIp 
gene insert and the pcDNA 3.1 vector. A, Both the pBS.PDIp and pcDNA 3.1 vector were subjected to 
double digestion using the Ecoffl and Xbal restriction enzymes. Restriction digests took place at 37 °C for 2 h. 
The PDIp insert and cut vector were separated by loading the digest reaction on a 1 % agarose gel. The insert 
and pcDNA 3.1 vector were cut out of the gel and purified by gel extraction methods. B, In order to determine 
the concentration of the purified vector and insert, a small amount of DNA (lanes 4-6) was loaded on a 1 % 
agarose gel together with DNA standards (lanes 1-3). A pcDNA 3.1 vector was loaded as a control (lane 6). 
Concentration was determined by pixel definition of these bands (See Table 2). 
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Purified PDIp insert and pcDNA 3.1 vector then required ligation. This was carried out 
using a vector:insert ratio of 1:20 at room temperature for 2 h using T4 ligase. Controls 
were also carried out using a) a ligation without an in,sert; this ruled out the possibility 
that colonies produced from the ligation were derived from vectors that had re-ligated 
due to single digestion or no digestion at all, b) a ligation without ligase; this ruled out the 
possibility that i f colonies grew, they were due to undigested vector. This also served as a 
negative control for vector/insert ligation. A positive control for transformation was 
carried out by transforming the original pcDNA 3.1 empty vector. 
After ligation, E. coli DH5a were subjected to aseptic transformation with 0.5 ng of 
DNA from the ligations. Small cultures of transformed E. coli were then plated on LB 
agar plates plus 100 pg ml"' ampicillin and incubated overnight. The resulting agar plates 
harboured colonies in the positive control pcDNA 3.1 transformation. No colonies were 
present on any of the agar plates from the ligation samples (data not shown). 
Ligation was repeated using the same purified vector and insert at different ratios. The 
original 1:20 ratio was kept, as well as including a 1:10 and L I ratio. The ligations were 
performed at room temperature but were carried out overnight in this instance. The 
resulting transformed E. coli produced colonies on agar plates from the positive pcDNA 
3.1 transformation but failed to produce colonies from any of the ligations (data not 
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shown). The ligation was attempted a third time, using only the 1:10 ratio. Temperature 
was kept constant in this instance by incubating the ligation reactions at 16 °C overnight. 
The resulting plates failed to produce any colonies yet again despite the control for 
transformation being successful (data not shown). 
Subsequently, new restriction sites were chosen for digestion. However, due to 
limitations on available sites, a blunt-ended restriction site had to be created using the 
Smal and EcoRV restriction enzymes. Hindlll was used as the sticky-ended restriction 
enzyme. Although blunt ended digestion is not ideal, a blunt-ended and a sticky-ended 
restriction site should allow correct orientation so long as the original vectors ful ly digest. 
Because of the incompatibility of restriction digestion temperatures, the digestions were 
completed sequentially. After double-digestion, fragments were run on a 1% agarose gel 
to isolate the vector and insert (Fig. lA). Fragments were cut out and purified. As 
previously, D N A concentration was estimated from the pixel definition of the image 
obtained from transillumination (Fig. IB). Ligation was carried out at a ratio of 
vector:insert of 1:20 using a brand new ligase and buffer as well as the old one in order to 
assess whether the buffer was a problem. Ligations were performed at room temperature 
for 2 h as per the original protocol. 
DH5a was once again transformed with the ligated DNA. The resulting plates showed no 
growth of colonies besides the positive for transfomiation, indicating that the old ligase 
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was not solely responsible for defective ligation (data not shown). Due to time constraints 
this investigation was not completed and ligation was not successful during the course of 
study. 
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Figure 7. Hindlll/Smal/EcoRV d igest ion, purification and concentrat ion determination of the 
PDIp gene insert a n d the pcDNA 3,1 vector. A, As in figure 6, however this time both pBS.PDIp 
and pcDNA 3.1 vector were subjected to difterent double digestions resulting in two different blunt ended 
restriction digests and a common 'sticky-ended' restriction digest. pBS.PDIp was digested using Hindlll and 
Smal restriction enzymes (lane 1), whilst the pcDNA 3.1 vector was digested using the Hindlll and EcoRV 
restriction enzymes (lane 2). The PDIp insert and cut vector were separated by loading the digest reaction on 
a 1% agarose gel. B, In order to determine the concentration of the purified vector (lane 5) and insert (lane 
4), a small amount was loaded on a 1% agarose gel together with DNA standards (lanes 1-3). An unrestricted 
pcDNA 3.1 vector was loaded as a control (lane 6). Concentration was determined by pixel definition of these 
bands. 
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3.3.3 Discussion 
In order to fully understand the redox role of PDI and its homologs, we must not only 
study the interactions of oxidoreductases with their substrates, but also their source of 
oxidising equivalents, the Eros. Classical PDI has been shown to bind both Erol -La and 
Erol-LP (Benham et ciL, 2000; Dias-Gunasekara et «/., 2005). Some human homologs of 
PDI, however, do not seem to bind some human Eros (Benham et ai, 2000). Since the 
recent identification of Erol-L(3, there has not been a systematic study of PDI homolog-
Ero interactions. 
Here, we attempted to characterise the binding of human Eros with the pancreas-specific 
PDI homolog PDIp. We initially attempted to use in vivo techniques using the 
endogenous expression of PDIp in the pancreatic cell lines available to us to study PDIp-
Ero interactions. Despite the fact that the rat cell line AR42J is a pancreatic acinar cell 
type, no endogenous PDIp was reproducibly detected in this cell line (Fig. IE). Thus, 
AR42J may not express PDIp, or the PDIp antibody may not recognise rat PDIp. This 
seems unlikely, since the antibody was raised against the whole protein rather than a 
peptide (Desilva et al, 1996). An alignment of human, murine and rat PDIp shows that 
the three proteins have very high homology (Fig. 8). 
Attempts were then made to study the interactions in vitro using a co-translation method 
where proteins that could potentially interact were translated together in a closed system. 
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Figure 8. A human, m o u s e and rat PDIp protein s e q u e n c e al ignment. PDIp protein sequence 
from human (Homo sapiens) (Hs) (AAH75029), mouse (Mus musculus) (Mm) (AA116672) and rat (Rattus 
norvegicus) (Rn) (XP_213263) were aligned using ttie T-coffee multiple alignment program. 
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Co-immunoprecipitation of complexes, however, proved diff icult using the rabbit 
reticulocyte translation method due to protein expression levels and non-specific binding. 
The data obtained did not allow us to define whether PDIp is able to interact with either 
E r o l - L a or Erol-Lp (Fig. 4B and C). Analysis of the IPs revealed that the technique was 
successful in isolating the myc-tagged proteins (data not shown), but no co-
immunoprecipitating PDIp could be detected (Fig. 4C). Using the same technique, neither 
E r o l - L a nor Erol-LP were detected co-immunoprecipitating with PDI; an observation 
that is contrary to published data (Fig. 5A). It is more likely that in vitro translation was 
inefficient, giving too little protein to observe PDIp/Ero interactions. Given more time, 
improving reticulocyte translation efficiency by testing temperature, using different 
concentrations of Cap analog and different concentrations of Mg"^ and DTT could be 
attempted. 
The cloning of the PDIp gene into a vector capable of being transfected into human cells 
was initially promising, with digestion and isolation of the PDIp gene proving successful 
(Fig. 6A and B). Despite perseverance, the ligation of the PDIp gene into the new vector 
was unsuccessful. Unfortunately, due to time restrictions, this study was not completed. 
Future work wil l concentrate on completing the optimisation of ligation to allow us to use 
transfection in order to study PDIp/Ero interactions. Transfection of PDIp and both Erol-
L a and Erol-LP wil l allow us to observe protein interactions both by co-
immunoprecipitation techniques and by using alkylating agents to trap any potential 
disulfide-bonded complexes. Site-directed mutagenesis of active site residues of both 
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PDIp and the Eros would allow for analysis of the active-site chemistry of PDIp. Recent 
evidence also points to the requirement of PDI and ERp44 for ER retention of the Eros by 
covalent interactions (Otsu et al., 2006). It would be interesting therefore to investigate if 
PDIp was also able to assist in the retention of the Eros in the ER. 
Both the substrate-binding properties of PDIp and the role of PDIp as a chaperone have 
been studied (Klappa et al., 1998a; Klappa et a!.. 1998b; Ruddock et al, 2000). Work 
now also needs to focus on substrate binding by studying the possible role of 
glycosylation and the b ' domain in substrate selection and binding. This wi l l help to 
elucidate the specific, specialised function of PDIp. a disulfide oxidoreductase that co-
exists with the ubiquitously expressed classical oxidoreductase PDI. 
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3.4 ER stress response signalling in HLA-B27-expressing cells 
3.4.1 Introduction 
The major histocompatability complex is a set of cell surface molecules involved in the 
presentation of peptides for immune surveillance (Pamer and Cresswell, 1998). 
Possession of the human MHC class I molecule human leukocyte antigen B27 (HLA-
B27) is highly associated with the development of a group of chronic inflammatory 
diseases known as the spondyloarthropathies (SpA). HLA-B27 is present in the 
overwhelming majority of individuals suffering from ankylosing spondylitis (AS) -
around 90-95% (Brewerton et ciL, 1973) - and is also associated with other forms of SpA, 
such as reactive arthritis (ReA) and inflammatory bowel disease (IBD)-associated SpA. 
However, possession of the allele alone is not enough to cause onset of AS since 5% of 
HLA-B27-positive individuals can develop the disease in the absence of family history. 
AS is typically characterised by inflammation of the axial skeleton, which manifests itself 
as lower back pain due to sacroilitis and/or spondylitis. 
The use of HLA-B27-expressing transgenic rodent models has proven vital in furthering 
our understanding of the development of the spondyloarthropathies as well as providing 
compelling evidence for a direct link between HLA-B27 expression and SpA 
pathogenesis. HLA-B27/hP2ni transgenic (B27-Tg) rats develop a multi-system 
spontaneous inflammatory disease closely resembling that of human SpA (Hammer et ai, 
1990; Taurog et ciL, 1999; Taurog et ciL, 1993; Taurog et ah, 1994; Tran et al, 2004). 
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Overexpression of HLA-B27 and hp?'!! initially results in colitis and localized 
inflammation, finally leading to inflammation of the gastrointestinal tract and joints 
(Hammer et al., 1990). Despite showing many of the characteristics of human SpA, B27-
Tg rats do not present the full phenotype of human AS, since these animals a) do not 
develop ankylosis of the axial skeleton and b) exhibit a more prominent inflammation of 
the bowel. 
A link between the development of SpA-related phenotypes and environmental factors 
has been suggested, since the development of disease in the B27-Tg rats is dependent on 
being housed in probiotic conditions. In contrast, when B27-Tg rats are housed in gemi-
free conditions, these animals do not develop the disease or any associated phenotypes 
(Taurog et al., 1994). Evidence from Rath and colleagues has shown that colonization of 
the gastrointestinal tract with normal gut flora, particularly Bacteroides ssp., is sufficient 
to trigger the development of characteristic gut inflammation (Rath et al., 1996). 
A large body of evidence points to an intimate link between intestinal inflammation and 
the pathogenesis of AS in patients. This evidence includes the prevalence of 
inflammatory bowel disease (IBD) in patients suffering from AS and family members of 
these patients (Dekker-Saeys et al., 1978; Woodrow, 1985), antigenic and structural 
cross-reactivity between HLA-B27 and components of enteric bacteria (Scofield et al., 
1993; Williams and Raybourne, 1990) and diminished internalization of enteric bacteria 
by B27-expressing fibroblasts (Kapasi and Inman, 1992). In addition to this, several 
gastrointestinal and genito-urinary pathogens including Campylobacter ssp., Chlamydia 
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ssp., Salmonella ssp. and Shigella ssp. have been implicated as triggers of HLA-B27-
associated reactive arthritis (Colmegna et al, 2004). 
Since the presence of pathogens seems to be correlated with disease development, 
pathogenesis of the disease has been linked with the physiological role of the class I 
molecule. M H C class I molecules present intracellularly derived peptides to CD8^ 
cytotoxic T-lymphocytes (Pamer and Cresswell, 1998). Usually, these peptides are 
derived f rom self-proteins, however during infection by intracellular pathogens, foreign 
peptides are presented. It has been proposed that pathogenesis is a consequence of the 
presentation of a peptide or series of peptides specific to the B27 molecule (Benjamin and 
Parham, 1990). Residues in the peptide binding groove of HLA-B27 might allow the 
binding of joint-specific aithritogenic peptide(s), recognised by autoreactive T-
lymphocytes which may elicit a novel cytotoxic T-cell response leading to chronic 
inflammation. This remains a popular theory of pathogenesis since only a small number 
of polymorphic HLA-B27 subtypes are associated with the disease (Colbert et ah, 1994; 
D'Amato et ciL, 1995; Lopez-LaiTea el al, 1995). 
The possibility that peptides responsible for potential AS-associated autoreactivity are 
derived f rom self-proteins is still being disputed. Although B27 molecules binding 
bacterially-derived or indeed self-derived peptides have been discovered in the synovium 
of both sufferers of ReA and AS, no self peptides that may be targeted by T-cells have 
been defined (Herijiann et al., 1993; Kuon et al., 2001). Conversely, the search for 
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candidate bacterial arthritogenic peptides that may trigger inflammation in AS remains 
arduous (Smith et ai, 2006). 
Recent work has revealed that depletion of CD8aP^ T-lymphocytes by adult thymectomy 
plus short-term anti-CDSa mAb treatment fails to suppress the development of arthritis 
and colitis in B27-Tg rats (May et ai, 2003). However, these data did implicate a CD8^ 
monocyte population whose numbers expand in disease. Classical T cell recognition 
therefore does not appear to be required for pathogenesis. Interestingly, MHC class I 
molecules have been found to react with additional cell surface receptors including the 
killer immunoglobulin receptor (KIR), the leukocyte immunoglobulin receptor (LIR) and 
CD4^ receptors found on a variety of immune cells including natural killer cells (Allen 
and Trowsdale, 2004; Boyle et a/., 2001; Lopez-Lanea et a/., 2006). Taken together these 
data highlight the potential complexity of receptor-mediated autoreactive responses. 
The unusual cell biology of HLA-B27 has also been the subject of investigation in an 
attempt to elucidate the pathogenesis of AS. Allen and colleagues were the first to 
document that, in the absence of P2m, HLA-B27 is able to form disulfide-linked 
homodimers in vitro via its highly reactive, unpaired cysteine residue at position 67 
(Cys*"^ ) of the B pocket in the peptide-binding gi'oove (Allen et al., 1999). Since then, 
homodimers have been discovered at the cell surface. It appears that cell-surface 
heterodimeric HLA-B27 disassociates, heavy chains dimerise in endosomes and are then 
recycled back to the cell surface (Bird et al., 2003). These homodimeric HLA-B27 
molecules are able to be interact with killer immunoglobulin receptors (KIR) and 
Results Chapter 4 [35 
immunoglobulin-like transcripts (ILT) on T and B lymphocytes, N K cells and monocytes 
(Kollnberger et al., 2002). Recognition of aberrant forms of HLA-B27 may contribute to 
pathogenesis through a modulation of leukocyte function. 
Additionally, a distinct population of homodimers exists in the ER. This aberrantly 
folded, or misfolded, population is not due to the dissociation of P2m from a natively 
folded heterodimer, but rather the lack of/delayed association of P2i!! due to the 
architecture of the B pocket region of the heavy chain (Antoniou et al., 2004; Dangoria et 
al., 2002; Mear ef al., 1999). When a transgenic murine model lacking P2m was 
developed by Kingsbury and colleagues in 2000, it was shown that misfolding of 
endogenous class I molecules due to lack of P^ m was sufficient to cause spontaneous 
inflammatory disease (Kingsbury et al., 2000). Recently, evidence has shown that the 
formation of misfolded heavy chain dimers is related to the rate of assembly of the H L A -
B27 molecule in addition to residues flanking the reactive Cys*"^  residue (Antoniou et al., 
2004). 
How this ER-restricted population of homodimers might be related to SpA pathogenesis 
is still unclear, however, recent studies have focused on ER stress responses as a 
consequence of HLA-B27-associated misfolding (Turner et al., 2005). HLA-B27 heavy 
chains are thought to misfold as a consequence of the residues in the B pocket of the 
peptide-binding groove (Mear et al., 1999). Because of the unique residues in the H L A -
B27 B pocket, the peptide-binding groove is inefficient at loading antigenic peptide. 
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Prolonged retention of the class I molecule in the ER in its unfolded conformation may 
lead to abenant disulfide formation thought to be promoted by Cys''^ and possibly other 
Cys residues (Antoniou et al., 2004). Misoxidation of proteins in the ER can result in the 
dislocation and subsequent degradation of these proteins by ER-associated degradation 
(ERAD) (Trombetta and Parodi, 2003). Shortly after synthesis, some HLA-B27 
molecules have been shown to undergo cytosolic degradation (Mear et al., 1999) which 
may be the consequence of inefficiently folded and/or misfolded HLA-B27 in the ER. 
Newly synthesised proteins that fold slowly and/or unstably have been shown to 
preferentially bind the abundant ER chaperone immunoglobulin binding protein (BiP) 
(Hellman et al., 1999). Appropriately, evidence has been provided for the prolonged 
association of HLA-B27 with BiP in the ER (Tran et al., 2004). One job of the chaperone 
BiP is to retain misfolded proteins in the ER in order to prevent inefficiently folded 
proteins from exiting the ER into the secretory pathway. Thus, association of BiP with 
HLA-B27, although a quality control measure, may indeed serve to promote aberrant 
disulfide formation since misfolding is a consequence of prolonged retention in the ER. 
Continued retention of misfolded proteins in the ER and inefficient degradation of these 
aben ant proteins may lead to an accumulation of BiP-bound proteins. The consequence 
of exceeding the folding capacity of the ER is the activation of the unfolded protein 
response (UPR). The UPR is a series of cellular signaling pathways which monitor the 
folding capacity of the ER and seeks to resolve any imbalance. In mammals three 
signaling branches of the UPR have evolved involving the transmembrane proteins; 
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ATF6, IREl and PERK (Shi et al, 1998; Yoshida et al., 1998; Yoshida et al.. 2001). 
Upon detection of ER stress, these proteins regulate the folding capacity of the ER at the 
translational and transcriptional levels in an attempt to restore homeostasis by 
upregulating both genes involved in the ER-associated degradation of temiinally 
misfolded proteins and ER chaperones to facilitate the binding of newly synthesised 
polypeptides. 
Recently, Turner and colleagues provided evidence linking HLA-B27 misfolding in bone 
marrow-derived cells from B27-Tg rats with activation of the UPR (Turner et al., 2005). 
In this key paper, they also drew attention to the presence of pro-inflammatory cytokines 
in cells exhibiting UPR activation, proposing a possible role for IFN-y in the process. 
Another potential link between UPR activation and a pro-inflammatory effect is 
suggested by the recent study providing evidence that NF-KB is activated by ER stress-
induced reduction in the synthesis of the NF-KB inhibitor iKBa (Deng et al., 2004). The 
effects of an ER overload therefore could potentially upregulate a number of cytokines 
and chemokines dependent on NF-KB (Baeuerle and Henkel, 1994). 
Whether or not HLA-B27 misfolding is pathogenic remains to be seen. However, it is 
worth noting that accumulation of misfolded proteins has been shown to be pathogenic in 
polyglutamine diseases and common neurodegenerative diseases such as Alzheimer's and 
Parkinson's (Imaizumi et al., 2001; Yoneda et al., 2002). The consequence of UPR 
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signaling in HLA-B27-expressing cells wi l l also require investigation. Work now needs 
to focus on linking UPR activation in human disease. 
This chapter investigates the levels of UPR induction in typed lymphoblastoid cells -
positive for HLA-B27 - and the effects of the pharmacological agents DTT and 
tunicamycin on UPR induction. 
Results Chapter 4 139 
3.4.2 Results 
3.4.2.1 Differential effects ofDTT and tunicaniycin on XBPl processing 
In order to study the effects of HLA-B27 expression on ER stress, we initially optimised 
the system for detection of activation of the UPR. We used the I R E l / X B P l signalling 
pathway to initially detennine UPR activation using pharmacological agents. IREl is a 
transmembrane ER protein, which is kept in an inactive, monomeric form by BiP, bound 
to its lumenal portion. During an accumulation of misfolded and/or unfolded proteins, 
BiP preferentially binds to these abeiTantly folded proteins and is sequestered away from 
IREl , activating the signaling pathway. IREl then dimerises and consequently 
autophosphorylates resulting in activation of its site-specific endo-RNase activity. 
The target of IREl is the ubiquitously expressed Xhpl (X-box binding protem 1) 
message. The removal of a 26-nucleotide intron from Xbpl mRNA generates a 
translational frame shift producing a protein encoded by two different open reading 
frames (ORFs). The resulting X B P l protein acts as a transcription factor, targeting 
unfolded protein response elements (UPRE) upstream of many UPR-inducible genes, 
upregulating or activating their transcription (Lee et al, 2002; Shen et al, 2001; Yoshida 
2001). 
In order to detect activation of the I R E l / X B P l signalling pathway, we utilised the fact 
that the removal of the 26-nucleotide intron from Xhpl mRNA removes a unique Pstl 
site (Calfon et at., 2002). Thus, activation can be monitored by a simple PstJ digest of 
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Xhpl inRNA (Fig. 1). Initially the human acute monocyte cell line THPl was studied for 
levels of UPR induction with pharmacological agents. 
Dithiothreitol (DTT), a reductant able to stimulate misfolding by altering the oxidising 
environment of the ER and tunicamycin, an agent that prevents correct glycosylation, 
were used to promote ER stress and activate the UPR over a time course of either 0 , 3, 6 
or 24 hours (Fig. 2A and B). THPl cells were treated with 1 0 niM DTT or 1 0 |.tg/ml 
tunicamycin for the indicated time course; cells were then lysed for RNA extraction. 
Total cell RNA was then subjected to reverse transcriptase PCR (RT-PCR) using primers 
for Xhpl and p-actin as a control. Amplif ied X B P l cDNA was then digested with the 
P.S77 restriction enzyme to detect activation of IRE 1-mediated splicing. The resulting 
digest was then purified and run on a 2% agarose gel to separate the sensitive and 
resistant products. The products running higher in the gel are resistant to digestion and 
thus are the spliced form of XBPl (XBPl (S)). These products represent activation of the 
UPR. Products running lower in the gel are sensitive to the digestion by Pstl and thus 
remain unspliced (XBPl (U)) (Fig. 1) . 
At time point 0 h, with no treatment, Xbpl niRNA existed at a low level of expression 
and as a doublet running at the height of the unspliced, inactive form of X B P l (Fig 2A 
and B, lane 1) . This doublet of 289 and 255 nucleotides is the product of Pstl digestion. 
Upon treatment of cells with DTT for 3 h, IREl-mediated XBPl processing was induced 
resulting in a single band representing the spliced version of XBPl (Fig 2A, lane 2). 
Upon DTT treatment for longer periods of 6 and 24 h, XBPl continued to be processed. 
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indicated by the persistence of the resistant band higher in the gel (Fig. 2/\, lanes 3 and 
4). Conversely, when cells were treated with tunicamycin, a doublet persisted 
representing the spliced version of XBPl (Fig. 2B, lanes 2 and 3). The top band in the 
doublet ran at the same height to that of the DTT induced resistant band. The lower band 
therefore must represent a nucleic acid sequence of smaller length to the band running 
above it. The presence of this smaller product may be a consequence of a further splicing 
or processing event. Stimulation with tunicamycin for 24 h, however, resulted in a single 
resistant species (Fig. 2B, lane 4). THPl cells partially recovered from tunicamycin 
stimulation, indicated by the reemergence of the sensitive, unspliced species after 24 h 
(Fig. 25, lane 4). This is in contrast to DTT treatment, which kept X B P l processing 
switched on after 24 h treatment (compare Fig. 25, lane 4 with Fig. 2/1, lane 4). This was 
surprising, as one would expect DTT to become oxidised after such an extended period of 
time in culture medium due to the fact that it is a labile reductant. 
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Figure 1. PstI digestion as a technique for analysing XBP1 processing. When inactive XBPl 
RNA is spliced, a 26 nucleotide intron is removed containing a unique Pst1 site. Upon digestion of inactive 
XBP1 RNA, two fragments are generated of 255 and 289 nucelotides (nt) due to the presence of the Pst1 
site. Activated (spliced) RNA however is not digested by the restriction enzyme due to its removal by IRE1 
and thus migrates as a single 518 nt fragment. 
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Figure 2. DTT and tunicamycin induce different pathways of XBP1 processing. A, THP1 cells 
were stimulated with (lanes 2-4) DTT or without (lane 1) for given time periods and lysed in TRIreagent. Total 
cell RNA was subjected to RT-PCR for XBP1 and p-actin. Total XBP1 PGR product was digested with Pst1 
enzyme, purified and run on 2% agarose gel to resolve the resistant, spliced product (XBPl (S)) and the 
digested, unspliced produced (XBP1 (U)). B, Cells were stimulated with tunicamycin (Tm) (lanes 2-4) or 
without (lane 1) for given time periods and analysed as in A. 
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3.4.2.2 XBPl processing in HLA-B27-positive lymphoblcistoid cell lines 
After characterising UPR induction in THPl cells using DTT and Tm as stimulants, we 
investigated the level of XBPl processing in immune cells expressing HLA-B27. We 
chose typed lymphoblastoid cell lines W E W A K l , positive for subtype HLA-B27*04 and 
HOM-2 and JESTHOM, both positive for subtype HLA-B27*05. Both HOM-2 and 
JESTHOM cell lines are known to have come from patients suffering from AS. 
We examined the sensitivity of these cell lines to UPR induction upon treatment with 
both DTT and tunicamycin (Fig. 3). In addition, we used the THPl cell line studied 
previously as a control. We treated THPl cells with lipopolysaccharide (LPS) for 4 days 
to stimulate the differentiation of THPl monocytes to adherent macrophages. This 
differentiation results in a reorganisation of the ER. Treatment with LPS however, was 
not sufficient to activate XBPl processing, as expected (Fig. 3, compare lanes 11 and 10). 
In the absence of ER stress-inducing stimuli, W E W A K l , HOM-2 and JESTHOM 
showed higher levels of XBPl processing than that of the untreated monocytes (Fig. 3, 
compare lanes 1, 4 and 7 with lanelO). A l l three of these cell lines showed similar levels 
of spliced and unspliced X B P l RNA, the spliced version migiating as a singlet. Upon 
treatment with DTT however, full activation of X B P l splicing was achieved, indicated by 
the loss of the unspliced X B P l species and an increase in intensity of the resistant band 
(Fig. 3, compare lanes 2, 5 and 8 with lanes 1, 4 and 7). In contrast, treatment with 
tunicamycin resulted in a small increase in activation of XBPl processing over the non-
treated control (Fig. 3, compare lanes 3, 6 and 9 with lanes 1, 4 and 7). Tunicamycin-
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inclucecL processed X B P l migrated as a doublet in W E W A K l cells but the lower band 
was very faint in both HOM-2 and JESTHOM ceil lines (Fig. 3. lanes 3, 6 and 9). It 
appears evident that the HLA-B27-expressing lymphocytes studied, show backgiound 
levels of XBPl processing above that of the non-HLA-B27-expressing THPl cells. 
XBPl processing in lymphoblastoid cell lines shows a cell-line variation in response to 
tunicamycin treatment (Compare Fig. 3 lanes 3 with lanes 6 and 9). Tunicamycin 
treatment on W E W A K l cells resulted in the generation of similar sized spliced products 
as those generated from the 6 h tunicamycin treatment of monocytic THPl cells 
(compare Fig. 3, lane 3 with Fig. 2B, lane 3). Spliced products generated from 
tunicamycin treatments of HOM-2 and JESTHOM cell lines are similar to those 
generated by 24 h treatment of THPl cells (compare Fig. 3, lanes 6 and 9 with Fig. 2B, 
lane 4). Thus, we conclude that different cell lines may begin to restore homeostasis at 
different rates when UPR is activated using the agent tunicamycin indicating a possible 
cell line-specific response. 
Consistent with figure 2, processing of X B P l using different stimuli results in either a 
doublet or smeared singlet with tunicamycin (compare Fig. 2B, lanes 2-4 with Fig. 3, 
lanes 3, 6 and 9) or a sharp single band with DTT, running at the same height as the 
lower band in the doublet seen with tunicamycin treatment (Fig. 2A, lanes 2-4 and Fig. 3 
lanes 2, 5 and 8). The different products of IRE 1-mediated splicing lead us to conclude 
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Figure 3. HLA-B27-positive lymphoblastoid cell lines show background levels of UPR 
signalling. WEWAK1 cells were stimulated with DTT (lane 2), tunicamycin (Tm) (lane 3) or mock 
treated (lane 1). Similarly, lymphocyte cell lines HOM-2 and JESTHOM were stimulated either with 
DTT (lanes 5 and 8) or with Tm (lanes 6 and 9) or mock treated (lanes 4 and 7). The monocytic cell 
line THP1 was stimulated with lipopolysaccharide (LPS) as a control (lane 11) or mock treated (lane 
10). Cells were then lysed and subjected to techniques described in Fig. 2 in order to resolve both 
activated and inactivated forms of XBP l . 
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that DTT- and tunicamycin-induced XBPl processing may occur via different pathways. 
Sequencing of these products is required to clarify this further. 
Notably, the background levels of UPR activation seen in all three of the untreated H L A -
B27-expressing lymphocytes are similar to those of the tunicamycin treatments of H O M -
2 and JESTHOM cell lines. Thus, X B P l processing in non-stimulated cells may occur 
via a tunicamycin-like pathway as opposed to a DTT-like pathway. The unstimulated 
cells show band architecture similar to that of the recovering 24 h tunicamycin-treated 
THPl cells (compare Fig. 3, lanes 1, 4 and 7 with Fig. 25, lane 4). I f indeed, a 
tunicamycin-induced singlet represents a UPR intermediate on the way to recovery of 
homeostasis, then HLA-B27-expressing cells may exhibit intennediate activation of the 
UPR. Whether or not X B P l processing and UPR induction is a consequence of HLA-B27 
misfolding remains to be seen. 
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3.4.2.3 Misoxidation of MHC class I heavy chains inchices XBPl processing 
in HeLa cells 
Since HLA-B27-positive lymphocytes induced activation of the UPR in the absence of 
pharmacological agents, we were now interested in whether or not misfolding of class I 
molecules would trigger X B P l processing. In order to do this, we transfected the human 
cervical carcinoma cell line HeLa with the B27 subtype HLA-B27*05. Previous work has 
shown that overexpression of HLA-B27*05 in HeLa cells causes misoxidation of heavy 
chains and the formation of disulfide-dependent high-molecular weight complexes 
(Saleki et «/., 2006). Cells were lysed in the presence of an alkylating agent in order to 
trap any free disulfides thus, preserving any disulfide bonds present at lysis. Post-nuclear 
cell lysates were separated by SDS-PAGE under non-reducing (NR) and reducing (R) 
conditions and immunoblotted. Transfected cell lysates were analysed by Western 
blotting for misoxidation using the pan-MHC class I HC antibody HCIO (Fig. 4A). SDS-
PAGE resolved the class I heavy chain in HLA-B27*05 transfected and mock transfected 
lysates indicating the presence of endogenous MHC class I (Fig. AA, lanes 1-4). Under 
non-reducing conditions, high-molecular weight complexes were resolved in the B27*05 
transfected iysates (Fig. 4/4, lane 1). Upon reduction of this sample with DTT, the 
majority of high-molecular weight species were disrupted and observed instead as a 
single species (Fig. 4A, lane 3). No disulfide-dependent complexes were resolved in the 
mock transfected samples (Fig. 4A, lanes 2 and 4) indicating that misoxidation was due 
to the overexpression of HLA-B27*05 and not endogenous class I molecules. Lysates 
were also immunoblotted for the presence of PDI as a control (Fig. 4A, lanes 5 and 6). 
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In parallel, Iransrected cells were lysed with tri reagent for subsequent RT-PCR analysis. 
Total cell RNA was extracted and both XBPl and (3-actin cDNA was amplified using 
RT-PCR techniques. As previously described, amplified XBPl cDNA was digested with 
Pstl restriction enzyme and run on a 2% agarose gel to resolve the two XBPl species. 
As controls, HeLa cells were treated with both DTT and tunicamycin for 6 h, lysed and 
analysed for X B P l processing in the normal way. Consistent with results from both 
T H P l cells and the lymphoblastoid cell lines, induction of the UPR by tunicainycin 
resulted in the generation of a two resistant, spliced XBPl products migrating as a 
doublet (Fig. 4S, lane 2). Similarly, UPR induction by DTT in HeLa cells resulted in a 
single resistant XBPl band, also consistent with previous work (Fig. 4 f i , lane 6). When 
mock transfected cells were analysed for UPR induction, they showed very low levels, in 
line with the untreated HeLa cells (compare Fig 45, lane 3 with lanes 1 and 5). In 
contrast, transfection of HeLa cells with HLA-B27*05 resulted in activation of XBPl 
processing (Fig. 4Z?, lane 4). Furthermore, the spliced products migrated as a doublet, 
consistent with the lymphoblastoid results suggesting that possession of HLA-B27 
activates XBPl processing in a similar fashion to that of tunicamycin. Moreover, these 
data now link UPR activation not only with possession of HLA-B27 but with the 
misoxidation and abeiTant formation of M H C class I heavy chains. 
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Figure 4. UPR induction as a consequence of IVIIHC class I IHC misoxidation. A, HeLa cells 
were transfected with the HLA-B27*05 construct (lanes 1, 3 and 5) or mock transfected (lanes 2, 4 and 6). 
Post-nuclear lysates were then analysed under reducing (R) (lanes 3-6) or non-reducing (lanes 1 and 2) 
conditions by 8% SDS-PAGE. Proteins were transferred and imnnunoblotted for the presence of tVIHC class 
I heavy chains using the monoclonal antibody HC-10 (lanes 1-4) or with anti-PDI (lane 5 and 6) as a 
control. B, HeLa cells were treated with DTT (lane 6) or tunicamycin (Tm) (lane 2) or mock treated (lanes 1 
and 5) for 6 h. RNA was extracted and XBPl RNA analysed as in Fig. 2. As in A, HeLa cells were 
transfected with HLA-B27*05 (lane 4) or mock Iransfected (lane 3) but this time analysed for XBP1 
processing. 
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3.4 .3 Discussion 
3.4.3.1 Differential effects of DTT and tunicamycin on XBPl processing 
A recent paper by DuRose and colleagues highlighted the apparent complexity of the 
unfolded protein response to different forms of ER stress (DuRose et a!., 2006). Their 
studies suggested that different branches of the UPR were able to respond to specific 
inducers of ER stress with distinct sensitivity. Specific branches of the UPR differed in 
the rapidity of their response to specific ER stresses, allowing DuRose and colleagues to 
propose the existence of additional regulatory mechanisms or components in the UPR. 
Consistent with this, we provide evidence that IRE 1-mediated XBPl processing can 
discriminate between different stimuli (Fig. 2A and 5) . We demonstrate that induction of 
XBPl processing by DTT and tunicamycin generates distinct XBPl products. We 
propose that the ability of the UPR to discriminate between different stimuli is due to the 
existence of distinct pathways of XBPl processing. These pathways may be uniquely 
sensitive to different modes of induction. 
Regulation of UPR activity could potentially take place at both the IREl activation level 
and the X B P l splicing level in the XBPl processing pathway. The recent publication of 
the human IRE l a luminal domain structure has allowed identification of a conserved 
dimer interface and shown that this interface is required for autophosphorylation (Zhou et 
ah, 2006). I f however, differential processing of X B P l was regulated further 
downstream, IREl RNase activity or mammalian ligase activity may be involved in 
inducer-specific UPR induction. 
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The reproducibility of these data within and across different cell lines justifies further 
investigation. Differentially spliced products induced by DTT and tunicamycin would 
require purification and subsequent sequencing to aid the elucidation of their function. 
The ability of tunicamycin-induced XBPl processing to progress from generating two 
spliced products upon both 3 h and 6 h treatment to a single spliced product upon 
treatment for 24 h is interesting (Fig. 15 compare lane 4 with lanes 2 and 3). This 
difference may be due to THPl cells beginning to recover from tunicamycin-induced ER 
stress. Is this recovery a direct consequence of the UPR or is recovery a consequence of 
the effect of tunicamycin weakening after 24 h? Despite DTT readily becoming oxidised, 
XBPl processing is 'switched-on' 24 h after DTT is provided to the cells. Analysis of 
DTT treatment in excess of 24 h may allow us to see i f any recovery of XBPl processing 
occurs. Moreover, can XBPl processing be recovered by washing out DTT or by adding 
an oxidant? Coinparisons of the effect of other reductants such as p-2 mercaptoethanol 
may help aid our understanding of XBPl processing. Analysis of the direct effects of 
these agents - disruption of ER oxidation with DTT and disruption of glycosylation with 
tunicamycin - over the time course in parallel with the effects on XBPl processing and 
other branches of the UPR might also aid our understanding of what is happening here. 
3.4.3.2 HLA-B27-positive cells show pre-activation of the UPR 
Here, we provide evidence that possession of the MHC class I allele HLA-B27 in 
lymphocytes results in a background level of X B P l processing not seen in inonocytic 
cells (Fig. 3). This pre-activation of HLA-B27-positive lymphocytes appears to be similar 
to that of tunicamycin-induced XBPl processing since IREl-mediated splicing of X B P l 
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RNA results in two products of the same size. This background UPR induction in 
lymphocytes may or may not be a consequence of chronic misfolding in the ER. Analysis 
of the oxidation status of proteins in the ER using the conformation-specific antibodies 
HC-10 and M E l may further our understanding in this respect. 
A l l three lymphoblastoid cell lines - W E W A K l , HOM-2 and JESTHOM - showed pre-
acfivation of X B P l splicing. Despite only differing by three residues, the B27 subtypes 
HLA-B27*04 - expressed in W E W A K l cells - and HLA-B27*05 - expressed in both 
HOM-2 and JESTHOM cells - have been shown to differ in their disulfide-dependent 
conformafions (Saleki et al., 2006). The subtype HLA-B27*04 is associated with AS; 
predominantly in the Asian population, and HLA-B27*05 - sometimes refened to as the 
'parent' subtype since it is the most common - is also associated with the development of 
the SpAs (Reveille, 2006). Indeed, the immortalised cell lines HOM-2 and JESTHOM 
were believed to be from AS sufferers. It is unfortunate that the clinical details of the 
W E W A K l cell line are unclear. Future work wil l concentrate on studying and comparing 
lymphocytes positive for HLA-B27 with cells from pafients suffering from AS. To 
further confirm pre-acfivafion of the UPR in these cell lines, studies wil l also be targeted 
towards the IREl and PERK branches of the UPR. 
In order to show whether class I misfolding triggered the UPR, we used the human 
carcinoma cell HeLa, into which we overexpressed the subtype HLA-B27*05. We 
demonstrate that pre-activation of the UPR is caused by the formation of a high-
molecular weight, disulfide-dependent, misoxidised ladder of class I heavy chains due to 
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overexpression (Fig. 4/1). Consistent with the lymphoblastoid cell lines. HLA-B27-
restricted XBPl induction showed similarities to activation of XBPl processing induced 
by tunicamycin. Thus, we conclude that tunicamycin is a better mimic of UPR induction 
by MHC class I heavy chain misoxidation. 
Although this work further con^oborates that of Turner and colleagues' (Turner et al., 
2005), the link between MHC class I misfolding and AS pathogenesis remains unknown. 
Activation of the UPR or the ER overload response has been hypothesised as integral in 
the increased production of inflammatory cytokines in monocytes/macrophages (Baeuerle 
and Henkel. 1994; Colbert, 2000). The potential result of increased levels of N F - K B , 
TNF-a and interleukins could in fact be the stimulation of MHC class I heavy chain 
expression, further adding to the problem (Ikawa el al., 1998) as well as direct 
inflammation as a consequence of ER stress (Zhang et al., 2006). 
The role of ER stress responses to both misoxidation and pharmacological agents appears 
to be a complex one. Recently, N F - K B activation has been shown to require 
phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF2) by the PERK 
branch of UPR (Deng et al., 2004; Jiang et al., 2003). How intimately linked the ER 
overload response and UPR are is currently unknown. How misfolding and associated 
UPR induction might function in individuals with the disease is also unknown. Thus, 
work on patient cells wi l l serve to aid our understanding in this respect. 
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4. Final Discussion 
4.1 The importance of FAD and Ero-Ero dimerisation in oxidative protein 
folding 
In eukaryotes, disulfide bond formation is catalysed by the PDI-Ero system, a partnership 
that minors the prokaryotic DsbA-DsbB redox cycle in the periplasm. Unlike the 
prokaryotic system, disulfide bond formation is not linked to respiration, but instead 
utilises the flavin FAD (Tu et al.., 2000). The ability of FAD to couple its reoxidation to 
molecular oxygen (Tu and Weissman, 2002) allows for the reoxidation of Ero and the 
subsequent transfer of oxidising equivalents to PDI. The mechanisms by which oxidising 
equivalents are passed from molecular oxygen through to PDI is not ful ly understood. 
Together with the work of Dias-Gunasekara and colleagues (Dias-Gunasekara et al., 
2005), we show that the human Ero l -Lp protein is able to form homodimers in vivo 
(Chapter 3.1, figure 3). Previous work has shown that both Ero 1-La and Erol-Lp 
associate with PDI in a redox-dependent manner (Benham et al., 2000; Dias-Gunasekara 
et al., 2005). Since the Ero 1-La C-X-X-C-X-X-C mutant C391A can rescue the 
temperature-sensitive yeast erol-1 mutant despite exhibiting reduced affinity for PDI, 
these data suggest that Ero-PDI association and Ero dimerisation may be important in 
maintaining the oxidative folding pathway in the ER. Further work by Dias-Gunasekara 
and colleagues has revealed that dimerisation is pardy controlled by the C-X-X-C-X-X-C 
motif (Dias-Gunasekara et al, 2005). Homodimers detected in this study are most likely 
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a consequence of both covalent and non-covalent association. Ti ie funct ional significance 
o f Erol -L(3 homodimers is unknown. Future work w i l l endeavour to elucidate the role o f 
dimeric Erol-LP in oxidat ive protein fo ld ing . 
The mechanism by w h i c h F A D passes oxidising equivalents to Fro is still not f u l l y 
understood. By ut i l i s ing mutants o f the human E r o l - L p protein, we were able to study 
the effect of G252S and H 2 5 4 Y mutations in the F A D - b i n d i n g site on homodimerisation 
o f Erol-LP and interaction w i t h P D I . Association of the F ro 1-LP mutants with P D I was 
impaired (Chapter 3 . L f igure 5). Thus, Fro 1-LP may require bound-FAD in order to f o r m 
ef f ic ient covalent associations wi th PDF The presence o f the co-factor may be essential 
fo r recognition and subsequent b ind ing o f PDI by E r o l - L p . However, recent evidence 
has suggested that yeast E r o l p is f a i r ly non-specific in its recognition of thioredoxin 
domains (Kulp et al, 2006). Non-covalent Ero-PDI interactions were largely unaffected, 
suggesting that interaction between E r o l - L p and P D I can occur in a disulf ide and f l a v i n -
independent manner. Ero-Ero interactions, however, were not affected by mutations in 
the FAD-b ind ing site, suggesting that the phenotypes observed in the yeast erol-1 and 
erol-2 mutants may not be accredited to the failure o f E r o l p to f o r m homodimers. 
The recent publication o f the E r o l p crystal structure has a l lowed us to generate a possible 
Ero homodimer model a l l owing us to further understand the role o f F A D in both 
homodimer format ion and Ero reoxidation (Chapter 3 .1 , f igure 14). In this model, the 
l ike ly site for P D I b inding is away f r o m the dimer interface, suggesting that the format ion 
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o f E ro -PDl and Ero-Ero complexes are not necessarily in i i tua l ly exclusive. The two 
bound-FAD molecules sit near the dimer interface. In light o f this, it seems unusual that 
mutations in the FAD-b ind ing site were unable to affect homodimerisat ion. 
This work highlights the complex i ty o f oxidative protein fo ld ing in the mammalian 
system. It was not previously k n o w n that Eros f o r m homodimers in vivo, or i f the absence 
o f bound F A D is able to prevent Ero-PDI association, thus this work significantly 
enhances our knowledge on the molecular mechanisms that underlie disulf ide bond 
fo rmat ion . Future work w i l l focus on further elucidating the mechanism behind the 
passing o f oxidising equivalents f r o m F A D to Ero, the effect o f F A D binding on F D l 
recognit ion and the role o f F A D in Ero dimer stability. Site-directed mutagenesis 
experiments can be planned that could determine whether, by targeting the dimer 
interface, the process of d i su l f ide bond format ion could be manipulated. 
4.2 Interactions of the pancreatic PDIp with the Eros 
In order to understand the redox roles o f P D I and its homologs, their interactions with the 
Eros must be studied. W e studied the pancreas-specific P D I homolog, PDIp. The 
restricted tissue distr ibution o f P D I p suggests a role in the oxidative f o l d i n g o f pancreas 
specific proteins. However, P D I is also present in the same pancreatic acinar cells where 
PDIp can be found (Dias-Gunasekara et ah, 2006). It has also been shown that P D I is 
able to interact wi th some o f the same substrates as PDIp (Klappa et al, 1995), 
suggesting a level o f funct ional redundancy in the system. 
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Using //( vitro translation techniques we studied the binding of PDIp wi th E r o l - L a and 
Ero l -Lp . N o PDIp-Ero interactions could be detected (Chapter 3.3, f igure 4) . This was 
probably a consequence o f low translation ef f ic iency. Interactions between the Eros and 
P D I cou ld also not be detected using this method (Chapter 3.3, f igure 5) suggesting that 
in vitro translation was not f u l l y optimised. Attempts were also made to transfect PDIp 
in to mammalian cells. The c D N A was successfully liberated f r o m pBS and pur i f ied 
(Chapter 3.3, f igure 6 and 7). Future work w i l l concentrate on op t imis ing l igation for 
mammal ian transfection. This w i l l a l low us to study the molecular detail o f PDIp-Ero 
interaction and experiments can be planned to mutate the active-site cysteines o f both 
redox proteins in order to elucidate their mechanism o f interaction. I t is possible that the 
mode o f interaction between PDIp and the Eros - further to substrate specif ici ty - is able 
to account fo r its specialisation in the pancreas, especially since distr ibut ion o f Erol-Lp 
overlaps wi th that o f PDIp. 
4.3 Characterisation of a polyclonal anti-Erol -Lj3 antibody 
Polyclonal antibodies are essential tools f o r studying protein interactions by co-
immunoprecipi ta t ion and immunoblo t t ing . Here, we characterised a new polyclonal 
antibody raised against Erol-Lp. 
The B 2 antibody was successful at recognising Erol-LP in immunoblots (Chapter 3.2, 
f igure 1) and was able to isolate Erol-Lp f r o m transfected lysates by 
immunoprecipi tat ion methods (Chater 3.2, f igure 3). This w i l l a l low us to isolate E r o l -
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LP and any proteins complexed eitiier covalently or non-covalently w i t h Erol-Lp. This 
has practical implications, since this antibody can now aid characterisation o f the 
interactions o f PDIp wi th Erol-Lp by co-immunoprecipitat ion. Importandy, the B2 
antibody d id not cross-react w i th human E r o l - L a (Chapter 3.2, f igure 4) despite 
potential ly sharing a number of epitopes. 
4.4 Misoxidation of HLA-Bl? and induction of the unfolded protein 
response 
Misox ida t ion o f the M H C class 1 molecule H L A - B 7 may have implicat ions in the 
pathogenesis o f ankylosing spondylitis ( A S ) . M i s f o l d i n g of H L A - B 2 7 has recently been 
l inked to induct ion o f the unfolded protein response (UPR) using macrophages derived 
f r o m bone marrow o f H L A - B 2 7 transgenic rats (Turner et a/., 2005). 
Here we provide novel evidence l i n k i n g the misoxidat ion o f H L A - B 2 7 in H e L a cells to 
activation o f the UPR via IREl -med ia ted X B P l splicing. We show that pre-activation o f 
the U P R is caused by the format ion o f a high-molecular weight ladder o f class I heavy 
chains (Chapter 3.4, figure 4) . Addi t iona l ly , we demonstrate that possession o f the H L A -
B27 allele results in background levels o f X B P l processing in lymphoblastoid cell lines 
(Chapter 3.4, f igure 3). This pre-activation appears to be similar to that o f tunicamycin-
induced X B P l processing suggesting that H L A - B 2 7 may induce UPR using a s imilar 
pathway to tunicamycin. As part o f this study we also observed a distinct difference in 
the sensitivity o f X B P l splicing to tunicamycin and D T T (Chapter 3.2, f igure 2). The 
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generation o f distinct spliced X B P l products may suggest that X B P l processing is able 
to discriminate between different s t imul i ; a theory very recently proposed by DuRose and 
colleagues (DuRose et ah. 2006). 
Future w o r k w i l l focus on testing other branches o f the UPR such as I R E l and P E R K in 
order to distinguish whether or not they exhibi t a similar abil i ty to discriminate between 
s t imul i . Studying the UPR response to other s t imuli such as thapsigargin and ca lc ium 
ionophores such as calcimycin (A23187) w i l l fur ther elucidate the sensitivity o f the U P R 
machinery to d i f ferent s t imul i . The abi l i ty o f H L A - B 2 7 expression and m i s f o l d i n g to pre-
activate X B P l spl icing must also be investigated further. Use of stably transfected H L A -
B27 cell lines w i l l al low us to determine whether UPR induced by misoxidat ion can be 
attenuated w i t h t ime. 
Taken together, this work adds to that o f Turner and colleagues (Turner et al., 2005) by 
coupl ing misoxidat ion o f class I heavy chains to induction o f the UPR. Given that 
induction o f the UPR can be l inked to in f l ammat ion (Zhang et ai, 2006) possibly through 
cytokines, chronic UPR signalling may be a component o f diseases such as A S . However , 
since cells at the site o f inf lammation in A S sufferers (e.g. dendritic and endothelial cells) 
may behave d i f fe ren t ly to the immort i l i sed lymphocytes observed here, the contr ibut ion 
o f UPR induct ion to inf lammat ion may best be studied in professional APCs. 
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4.5 Concluding Remarks 
This thesis addresses some important questions underlying the mechanisms behind 
oxidative protein f o l d i n g in the ER and the consequences of protein m i s f o l d i n g for the 
cel l . We explore the importance of F A D in the binding of PDI by E r o l - L p and 
demonstrate the existence o f Ero 1-LP homodimers (together wi th Dias-Gunasekara and 
colleagues). The interactions of members o f the oxidative protein f o l d i n g machinery 
define the process o f disulf ide bond format ion since these bonds are passed up a chain -
through a series o f electron transfers - to the substrate. Thus, understanding the 
associations o f members o f this system adds to our molecular knowledge o f oxidat ive 
fo ld ing . 
The consequence o f non-native fo ld ing o f proteins is not restricted to the ER, but has 
global physiological consequences. We show that responses to ER stress may be specific 
to di f ferent s t imul i and that misoxidation o f M H C class I heavy chains induces a cellular 
splicing event. This , in the context o f the work by Turner and colleagues (Turner et al, 
2005), demonstrates a l ink between misoxidat ion o f M H C class I heavy chains and 
induction o f the UPR. The f u l l role of U P R induct ion in AS pathogenesis remains to be 
addressed by future experimental work. 
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